https://curecurrent.com/trials/doctor-s-counselling-using-culturally-responsive-pamphlet-increased-mammogram-uptake-among-malay-muslim-women-in-singapo-31001https://curecurrent.com/trials/conquerfear-group-a-psychological-intervention-for-fear-of-cancer-recurrence-31002https://curecurrent.com/trials/breast-reconstruction-and-neoadjuvant-radiotherapy-31003https://curecurrent.com/trials/study-to-determine-the-utility-of-fes-pet-and-fdg-pet-in-the-prediction-of-response-to-hormone-therapy-in-women-with-est-31004https://curecurrent.com/trials/role-of-caregiver-in-the-clinical-pathway-of-patients-with-breast-and-prostate-cancer-31005https://curecurrent.com/trials/effects-of-mk-3475-pembrolizumab-on-the-breast-tumor-microenvironment-in-triple-negative-breast-cancer-31006https://curecurrent.com/trials/role-of-magnetic-resonance-fingerprinting-and-quantitative-mr-imaging-in-breast-cancer-31007https://curecurrent.com/trials/pilot-decentralized-clinical-trial-in-men-and-pre-and-post-menopausal-women-with-breast-cancer-and-a-specific-mutation-p-31008https://curecurrent.com/trials/pre-operative-immunotherapy-combination-strategies-in-breast-cancer-31009https://curecurrent.com/trials/retinoid-9cuab30-in-producing-a-biologic-effect-in-patients-with-early-stage-breast-cancer-31010https://curecurrent.com/trials/the-effect-of-metacognition-based-manualized-intervention-on-fear-of-cancer-recurrence-31011https://curecurrent.com/trials/real-life-treatment-patterns-with-cyclin-dependent-kinase-inhibitors-in-advanced-breast-cancer-in-portugal-reveal-study-31012https://curecurrent.com/trials/tumour-localisation-with-magnetic-clip-before-neoadjuvant-chemotherapy-31013https://curecurrent.com/trials/therapeutic-cancer-vaccine-ast-301-pngvl3-hicd-in-patients-with-breast-cancer-31014https://curecurrent.com/trials/sacituzumab-govitecan-combined-with-head-radiotherapy-for-her2-negative-breast-cancer-brain-metastases-31015https://curecurrent.com/trials/magnetic-resonance-imaging-mri-correlation-to-standard-of-care-imaging-and-pathology-correlation-in-breast-carcinoma-31016https://curecurrent.com/trials/the-effect-of-stress-ball-application-on-stress-anxiety-and-comfort-during-chemotherapy-in-women-with-breast-cancer-31017https://curecurrent.com/trials/combining-cem-and-magnetic-seed-localization-of-non-palpable-breast-tumors-31018https://curecurrent.com/trials/studying-the-association-between-environmental-exposure-to-pfas-and-breast-cancer-in-assiut-governorate-egypt-31019https://curecurrent.com/trials/retrospective-analysis-of-a-drug-metabolizing-genotype-in-cancer-patients-and-correlation-with-pharmacokinetic-and-pharm-31020https://curecurrent.com/trials/study-of-adct-301-in-patients-with-selected-advanced-solid-tumors-31021https://curecurrent.com/trials/utidelone-capsule-plus-capecitabine-cap-for-metastatic-breast-cancer-31022https://curecurrent.com/trials/ruxolitinib-in-estrogen-receptor-positive-breast-cancer-31023https://curecurrent.com/trials/evaluation-of-the-diagnostic-performance-of-a-bra-prototype-to-detect-breast-cancer-31024https://curecurrent.com/trials/a-study-of-sacituzumab-with-chemoimmunotherapy-to-treat-advanced-triple-negative-breast-cancer-after-prior-therapies-31025https://curecurrent.com/trials/implementing-acupuncture-and-chinese-herbal-medicine-into-palliative-care-31026https://curecurrent.com/trials/topical-keratin-in-treating-radiation-dermatitis-in-patients-with-breast-cancer-31027https://curecurrent.com/trials/home-combo-an-online-home-based-combined-exercise-intervention-for-women-with-breast-cancer-31028https://curecurrent.com/trials/peers-promoting-exercise-adoption-and-maintenance-among-cancer-survivors-31029https://curecurrent.com/trials/increasing-breast-cancer-screening-in-chinese-immigrants-31030https://curecurrent.com/trials/maternal-cancer-diagnosis-and-treatment-during-pregnancy-a-database-for-maternal-fetal-and-neonatal-outcomes-31031https://curecurrent.com/trials/immunotherapy-hormone-therapy-and-akt-inhibitor-for-premenopausal-er-positive-mbc-31032https://curecurrent.com/trials/a-text-based-intervention-in-improving-adherence-to-hormone-therapy-in-patients-with-stage-i-iii-hormone-receptor-positi-31033https://curecurrent.com/trials/gedatolisib-plus-talazoparib-in-advanced-triple-negative-or-brca1-2-positive-her2-negative-breast-cancers-31034https://curecurrent.com/trials/oncoliq-early-breast-cancer-detection-based-on-liquid-biopsies-and-micrornas-31035https://curecurrent.com/trials/globalsurg-3-quality-and-outcomes-in-global-cancer-surgery-31036https://curecurrent.com/trials/3d-ultrasound-microvessel-imaging-for-breast-masses-31037https://curecurrent.com/trials/real-world-effectiveness-of-palbociclib-in-combination-with-an-aromatase-inhibitor-31038https://curecurrent.com/trials/hypofractionated-radiation-therapy-for-patients-with-breast-cancer-receiving-regional-nodal-irradiation-31039https://curecurrent.com/trials/an-investigation-into-dielectric-assessment-of-permittivity-and-conductivity-in-human-using-a-novel-electrical-capacitan-31040https://curecurrent.com/trials/observational-study-on-the-sensitivity-of-neoadjuvant-immunotherapy-in-early-triple-negative-breast-cancer-31041https://curecurrent.com/trials/individualized-exercise-oncology-program-for-newly-diagnosed-breast-cancer-patients-31042https://curecurrent.com/trials/a-clinical-trial-of-breast-cancer-neo-adjuvant-therapy-based-on-molecular-pathway-in-fuscc-31043https://curecurrent.com/trials/microfluidic-device-to-diagnose-leptomeningeal-metastasis-in-breast-cancer-31044https://curecurrent.com/trials/vaccine-therapy-in-treating-patients-with-stage-iv-hla-a2-and-her2-positive-breast-or-ovarian-cancer-receiving-trastuzum-31045https://curecurrent.com/trials/study-of-azd2014-and-palbociclib-in-patients-with-estrogen-receptor-positive-er-metastatic-breast-cancer-31046https://curecurrent.com/trials/a-cohort-study-to-evaluate-genetic-predictors-of-aromatase-inhibitor-musculoskeletal-symptoms-31047https://curecurrent.com/trials/cost-of-using-fluorescence-to-green-of-indocyanine-for-the-detection-of-breast-cancer-31048https://curecurrent.com/trials/role-of-txa-in-patients-undergoing-breast-free-flap-reconstruction-31049https://curecurrent.com/trials/durvalumab-and-tremelimumab-before-surgery-in-treating-patients-with-hormone-receptor-positive-her2-negative-stage-ii-ii-31050https://curecurrent.com/trials/fast-forward-vs-hai5-31051https://curecurrent.com/trials/detect-iii-a-multicenter-phase-iii-study-to-compare-standard-therapy-lapatinib-in-her2-ve-mbc-patients-with-her2-ve-ctcs-31052https://curecurrent.com/trials/first-line-atezolizumab-paclitaxel-and-bevacizumab-avastin-in-mtnbc-31053https://curecurrent.com/trials/detect-iv-a-study-in-patients-with-her2-negative-metastatic-breast-cancer-and-persisting-her2-negative-circulating-tumor-31054https://curecurrent.com/trials/detect-v-chevendo-chemo-vs-endo-31055https://curecurrent.com/trials/evaluation-of-recurrence-risk-factors-in-locally-advanced-breast-cancer-patients-underwent-neoadjuvant-chemotherapy-31056https://curecurrent.com/trials/carboplatin-in-early-triple-negative-breast-cancer-trial-pearly-trial-31057https://curecurrent.com/trials/a-study-of-mk-2206-in-combination-with-trastuzumab-and-lapatinib-for-the-treatment-of-her2-solid-tumors-mk-2206-015-31058https://curecurrent.com/trials/breast-cancer-risk-from-sonographic-glandular-tissue-component-or-international-gtc-study-31059https://curecurrent.com/trials/a-patient-reminder-and-self-referral-via-online-patient-portals-and-text-messaging-to-improve-adherence-to-breast-cancer-31060https://curecurrent.com/trials/a-prospective-study-of-breast-cancer-patients-with-abnormal-strain-imaging-31061https://curecurrent.com/trials/effects-of-lymph-drainage-on-patients-with-axillary-web-syndrome-31062https://curecurrent.com/trials/efficacy-and-safety-of-hiloterm-device-for-the-prevention-of-peripheral-neuropathy-31063https://curecurrent.com/trials/clinical-treatment-of-refractory-breast-cancer-based-on-organoid-drug-sensitivity-results-31064https://curecurrent.com/trials/acupuncture-for-peripheral-neuropathy-induced-by-paclitaxel-in-early-stage-breast-cancer-31065https://curecurrent.com/trials/pre-operative-trial-for-breast-cancer-with-nivolumab-in-combination-with-novel-io-31066https://curecurrent.com/trials/chemotherapy-and-cognitive-deterioration-in-patients-with-operable-breast-cancer-impact-of-cognitive-rehabilitation-chem-31067https://curecurrent.com/trials/clinicopathological-parameters-of-her2-low-breast-cancers-31068https://curecurrent.com/trials/diffusion-weighted-mri-for-breast-cancer-screening-in-women-with-a-personal-history-of-breast-cancer-31069https://curecurrent.com/trials/breast-cancer-long-term-outcomes-on-cardiac-functioning-a-longitudinal-study-31070https://curecurrent.com/trials/is-it-feasible-self-affirmation-for-hereditary-breast-and-ovarian-cancer-genetic-counseling-31071https://curecurrent.com/trials/screening-contralateral-breast-cancers-in-patients-with-newly-diagnosed-breast-cancer-31072https://curecurrent.com/trials/value-of-tomosynthesis-in-breast-lesion-characterization-and-breast-cancer-staging-31073https://curecurrent.com/trials/virtual-exercise-on-elderly-breast-cancer-survivors-31074https://curecurrent.com/trials/diffusion-weighted-mri-for-diagnosis-of-multifocal-multicentric-breast-cancer-31075https://curecurrent.com/trials/long-term-oncologic-outcome-of-breast-conserving-surgery-in-breast-cancer-patients-with-brca1-2-mutations-31076https://curecurrent.com/trials/a-single-arm-single-center-open-clinical-study-31077https://curecurrent.com/trials/standard-follow-up-program-sfp-for-breast-cancer-patients-31078https://curecurrent.com/trials/neoantigen-dna-vaccine-alone-vs-neoantigen-dna-vaccine-plus-durvalumab-in-triple-negative-breast-cancer-patients-followi-31079https://curecurrent.com/trials/a-study-to-evaluate-safety-tolerability-of-immunotherapy-combinations-in-participants-with-triple-negative-breast-cancer-31080https://curecurrent.com/trials/linc00511-mir-185-3p-axis-and-mir-301a-3p-markers-for-breast-cancer-diagnosis-31081https://curecurrent.com/trials/sonography-for-covid-19-vaccines-related-reactive-lymphadenopathy-31082https://curecurrent.com/trials/a-study-of-xzp-3287-in-combination-with-fulvestrant-in-patients-with-advanced-breast-cancer-31083https://curecurrent.com/trials/18f-fmau-pet-ct-and-mri-for-the-detection-of-brain-tumors-in-patients-with-brain-cancer-or-brain-metastases-31084https://curecurrent.com/trials/a-study-to-evaluate-the-safety-and-tolerability-of-immunotherapy-combinations-in-participants-with-advanced-malignancies-31085https://curecurrent.com/trials/to-evaluate-the-efficacy-and-safety-of-disitamab-vedotin-combined-with-toripalimab-sequential-chemotherapy-as-neoadjuvan-31086https://curecurrent.com/trials/electrosurgical-bipolar-systems-versus-conventional-electrocautery-after-slnbx-31087https://curecurrent.com/trials/the-impact-of-mindful-compassion-on-sexual-functioning-post-breast-cancer-treatment-31088https://curecurrent.com/trials/effect-of-bupivacaine-liposome-anterior-serratus-deep-block-on-chronic-pain-after-breast-cancer-surgery-a-randomized-con-31089https://curecurrent.com/trials/clinical-pilot-study-for-personalized-risk-based-breast-cancer-screening-31090https://curecurrent.com/trials/hair-care-product-use-among-women-of-color-31091https://curecurrent.com/trials/brass-mesh-bolus-in-rotational-post-mastectomy-radiation-therapy-31092https://curecurrent.com/trials/impact-of-pilates-method-on-myofascial-stiffness-cardiorespiratory-fitness-and-quality-of-life-in-breast-cancer-women-31093https://curecurrent.com/trials/pre-operative-radiation-and-veliparib-for-breast-cancer-31094https://curecurrent.com/trials/the-impact-of-socioeconomic-determinants-on-the-patient-reported-outcomes-in-young-breast-cancer-patients-after-breast-s-31095https://curecurrent.com/trials/efficacy-of-mr-hifu-ablation-of-breast-cancer-31096https://curecurrent.com/trials/dedicated-breast-ct-for-quantitative-breast-density-measurements-in-mexican-origin-women-in-southern-arizona-31097https://curecurrent.com/trials/streamlined-localization-using-scout-at-biopsy-streamloc-31098https://curecurrent.com/trials/a-study-of-ilb2109-and-toripalimab-in-patients-with-advanced-solid-malignancies-31099https://curecurrent.com/trials/evaluating-the-effect-of-a-mobile-audio-companion-elly-to-reduce-anxiety-in-cancer-patients-31100https://curecurrent.com/trials/neoadjuvant-dose-dense-ec-followed-by-abx-with-pd-1-for-triple-negative-breast-cancer-patients-31101https://curecurrent.com/trials/mitigating-toxicity-by-electronic-health-portal-mediated-interactive-monitoring-of-patient-reported-side-effects-31102https://curecurrent.com/trials/resistance-type-exercise-training-in-postmenopausal-women-survivors-of-breast-cancer-31103https://curecurrent.com/trials/shr-a1811-in-combination-with-adebrelimab-for-the-treatment-of-her2-low-expressing-metastatic-breast-cancer-31104https://curecurrent.com/trials/compare-efficacy-safety-and-immunogenicity-of-hlx02-and-herceptin-in-previously-untreated-her2-overexpressing-metastatic-31105https://curecurrent.com/trials/acupuncture-for-insomnia-in-breast-cancer-patients-undergoing-chemotherapy-31106https://curecurrent.com/trials/peri-gravidic-exposure-to-endocrine-disrupting-persistent-organic-pollutants-31107https://curecurrent.com/trials/compare-the-efficacy-and-the-safety-of-taxotere-and-nanoxel-m-as-neoadjuvant-chemotherapy-in-breast-cancer-31108https://curecurrent.com/trials/a-pilot-study-of-a-micro-organosphere-drug-screen-platform-to-lead-care-in-advanced-breast-cancer-31109https://curecurrent.com/trials/opera-incorporating-robotic-surgery-in-both-mastectomy-and-diep-flap-reconstruction-31110https://curecurrent.com/trials/individualized-piano-instruction-ipi-for-improving-cognition-in-breast-cancer-survivors-31111https://curecurrent.com/trials/association-of-pembrolizumab-infusion-time-and-efficacy-in-patients-with-non-metastatic-triple-negative-breast-cancer-tn-31112https://curecurrent.com/trials/prehabilitation-and-rehabilitation-in-breast-cancer-surgery-patients-a-pilot-study-31113https://curecurrent.com/trials/a-comprehensive-oncology-rehabilitation-and-exercise-core-program-among-breast-cancer-survivors-31114https://curecurrent.com/trials/effects-of-extracorporeal-shock-wave-therapy-eswt-and-low-intensity-laser-therapy-lllt-added-to-complete-decongestive-th-31115https://curecurrent.com/trials/prevalence-and-clinicopathologic-features-of-different-her2-level-in-chinese-breast-cancer-patients-31116https://curecurrent.com/trials/evaluation-of-the-effects-of-using-cooling-pillowcases-on-the-symptoms-of-hot-flushes-sleep-and-life-quality-31117https://curecurrent.com/trials/prospective-screening-and-differentiating-common-cancers-using-peripheral-blood-cell-free-dna-sequencing-31118https://curecurrent.com/trials/evaluation-of-endocrine-therapy-effects-of-host-immunity-in-early-stage-breast-cancer-31119https://curecurrent.com/trials/soy-isoflavones-and-breast-cancer-risk-reduction-31120https://curecurrent.com/trials/targeted-physiotherapeutic-treatment-for-aromatase-inhibitor-associated-musculoskeletal-pain-in-breast-cancer-survivors-31121https://curecurrent.com/trials/a-clinical-feasibility-study-of-a-photoacoustic-finder-31122https://curecurrent.com/trials/study-of-talimogene-laherparepvec-with-atezolizumab-for-triple-negative-breast-cancer-and-colorectal-cancer-with-liver-m-31123https://curecurrent.com/trials/simultaneous-hyperpolarized-1-13c-pyruvate-and-18f-fdg-pet-mrs-in-cancer-patients-31124https://curecurrent.com/trials/study-of-xl102-as-single-agent-and-combination-therapy-in-subjects-with-solid-tumors-quartz-101-31125https://curecurrent.com/trials/conversations-in-light-and-shadow-assessing-phototherapy-s-impact-on-breast-cancer-patients-31126https://curecurrent.com/trials/an-observational-study-to-evaluate-the-safety-and-efficacy-of-pegfilgrastim-neulasta-31127https://curecurrent.com/trials/the-effect-of-inspiratory-muscle-training-on-breast-cancer-patients-undergoing-surgery-31128https://curecurrent.com/trials/the-effect-of-self-breast-examination-training-on-the-belief-of-breast-health-31129https://curecurrent.com/trials/an-exploratory-study-to-evaluate-attention-biases-in-adults-with-multiple-sclerosis-breast-cancer-and-lung-cancer-31130https://curecurrent.com/trials/a-french-observational-study-of-indocyanine-green-for-patients-with-breast-cancer-having-a-sentinel-lymph-node-biopsy-31131https://curecurrent.com/trials/dp303c-versus-trastuzumab-emtansine-in-in-patients-with-her2-positive-advanced-breast-cancer-31132https://curecurrent.com/trials/hypnosis-for-pain-in-black-women-with-advanced-breast-cancer-a-feasibility-study-31133https://curecurrent.com/trials/a-retrospective-real-world-study-of-abemaciclib-in-hr-breast-cancer-31134https://curecurrent.com/trials/finasteride-mk-0906-and-male-breast-cancer-a-register-based-nested-case-control-study-mk-0906-162-2003-021-31135https://curecurrent.com/trials/vision-triple-negative-breast-cancer-sample-and-clinical-data-acquisition-study-31136https://curecurrent.com/trials/18f-fdg-pet-ct-imaging-for-breast-cancer-31137https://curecurrent.com/trials/outpatient-versus-tele-rehabilitation-among-post-surgical-breast-cancer-survivors-31138https://curecurrent.com/trials/creatine-supplementation-and-resistance-training-in-patients-with-breast-cancer-31139https://curecurrent.com/trials/multimodal-project-31140https://curecurrent.com/trials/neoadjuvant-5-fluorouracil-epirubicin-and-cyclophosphamide-fec-followed-by-weekly-paclitaxel-and-trastuzumab-in-her2-pos-31141https://curecurrent.com/trials/anti-inflammatory-diet-in-brc-patients-on-aromatase-inhibitors-31142https://curecurrent.com/trials/neoadjuvant-pembrolizumab-carboplatin-and-paclitaxel-in-triple-negative-breast-cancer-31143https://curecurrent.com/trials/effect-of-alpha-lipoic-acid-on-chemotherapy-induced-neurological-changes-in-breast-cancer-patients-31144https://curecurrent.com/trials/boost-irradiation-to-the-supraclavicular-area-among-high-risk-cn3c-breast-cancer-patients-31145https://curecurrent.com/trials/evaluation-of-breast-cancer-screening-program-at-assiut-governorate-31146https://curecurrent.com/trials/a-study-to-evaluate-the-efficacy-and-safety-of-tsl-1502-capsules-in-breast-cancer-patients-with-germline-brca-mutations-31147https://curecurrent.com/trials/letrozole-in-treating-breast-cancer-in-postmenopausal-women-with-stage-i-ii-or-iii-breast-cancer-previously-treated-with-31148https://curecurrent.com/trials/effects-of-a-manual-therapy-program-to-reduce-the-evolution-time-of-axillary-web-syndrome-31149https://curecurrent.com/trials/a-dose-escalation-expansion-study-of-mdk-703-in-patients-with-advanced-or-metastatic-solid-tumors-31150https://curecurrent.com/trials/omega-3-and-vitamin-d-supplementation-in-breast-cancer-women-31151https://curecurrent.com/trials/cipn-in-early-stage-breast-cancer-patients-31152https://curecurrent.com/trials/ql1706-plus-chemotherapy-as-neoadjuvant-therapy-in-early-high-risk-er-her2-breast-cancer-31153https://curecurrent.com/trials/ql1706-plus-chemotherapy-as-neoadjuvant-therapy-in-early-high-risk-tnbc-breast-cancer-31154https://curecurrent.com/trials/assessing-clinical-features-and-outcome-of-breast-cancer-in-palb2-mutation-carriers-the-palbreast-study-31155https://curecurrent.com/trials/comprehensive-analysis-of-predictors-of-the-treatment-with-pembrolizumab-and-olaparib-in-patients-with-unresectable-or-m-31156https://curecurrent.com/trials/improving-adherence-to-eht-among-breast-cancer-patients-31157https://curecurrent.com/trials/the-effects-of-short-term-preoperative-treatment-with-hormonal-therapy-on-gene-profiles-in-breast-cancer-31158https://curecurrent.com/trials/the-relationship-between-fatty-liver-and-breast-cancer-31159https://curecurrent.com/trials/added-value-of-preoperative-contrast-enhanced-mammography-in-staging-of-malignant-breast-lesions-31160https://curecurrent.com/trials/imaging-of-er-density-to-guide-and-improve-tailored-therapy-for-acquired-anti-hormonal-resistant-breast-cancer-31161https://curecurrent.com/trials/oncologic-cosmetic-and-patient-reported-outcomes-in-value-based-breast-surgery-oncopro-value-31162https://curecurrent.com/trials/strataxrt-for-the-prevention-and-treatment-of-radiation-dermatitis-in-breast-cancer-or-head-and-neck-cancer-patients-31163https://curecurrent.com/trials/molecular-imaging-of-fulvestrant-effects-on-availability-of-er-binding-sites-31164https://curecurrent.com/trials/sensitivity-and-predictive-value-of-frozen-section-of-sentinel-lymph-node-biopsy-in-post-neoadjuvant-setting-31165https://curecurrent.com/trials/ar-and-er-imaging-in-metastatic-breast-cancer-31166https://curecurrent.com/trials/knowledge-and-attitudes-regarding-healthy-lifestyle-and-health-behavior-change-in-cancer-patients-and-their-partners-a-p-31167https://curecurrent.com/trials/high-dose-chemotherapy-with-hematopoietic-stem-cell-rescue-for-high-risk-breast-cancer-long-term-follow-up-31168https://curecurrent.com/trials/optimizing-functional-recovery-of-breast-cancer-survivors-31169https://curecurrent.com/trials/onapristone-and-fulvestrant-for-er-her2-metastatic-breast-cancer-after-endocrine-therapy-and-cdk4-6-inhibitors-the-smile-31170https://curecurrent.com/trials/delayed-slnd-for-patients-with-breast-cancer-undergoing-primary-systemic-treatment-31171https://curecurrent.com/trials/hypofractionated-radiation-therapy-in-preventing-recurrence-in-patients-with-breast-cancer-after-surgery-31172https://curecurrent.com/trials/testing-the-addition-of-immunotherapy-with-hu5f9-g4-magrolimab-to-the-usual-parp-inhibitor-olaparib-for-treatment-of-met-31173https://curecurrent.com/trials/identifying-prognostic-variables-for-persistent-ul-dysfunctions-after-breast-cancer-treatment-reliability-and-validity-31174https://curecurrent.com/trials/relaxation-training-by-tele-rehabilitation-in-patients-with-breast-cancer-31175https://curecurrent.com/trials/label-free-raman-spectroscopy-for-discrimination-between-breast-cancer-tumor-and-adjacent-tissues-after-neoadjuvant-trea-31176https://curecurrent.com/trials/trastuzumab-in-treating-older-women-with-early-stage-breast-cancer-31177https://curecurrent.com/trials/identifying-prognostic-variables-for-persistent-upper-limb-dysfunctions-after-breast-cancer-treatment-31178https://curecurrent.com/trials/combination-neoadjuvant-chemotherapy-with-or-without-apatinib-for-her2-negative-breast-cancer-31179https://curecurrent.com/trials/study-of-oral-vinorelbine-plus-capecitabine-versus-taxane-gemcitabine-combinations-as-1st-line-chemotherapy-in-metastati-31180https://curecurrent.com/trials/remote-breast-cancer-screening-study-31181https://curecurrent.com/trials/a-window-trial-on-boswellia-for-breast-cancer-primary-tumors-31182https://curecurrent.com/trials/to-assess-efficacy-and-safety-of-oral-reparixin-in-patients-with-fatigue-and-locally-advanced-metastatic-breast-cancer-31183https://curecurrent.com/trials/supraclavicular-lymph-node-dissection-for-ipsilateral-supraclavicular-lymph-node-metastatic-breast-cancer-31184https://curecurrent.com/trials/clinical-efficacy-and-safety-of-incadronate-in-breast-cancer-with-bone-metastases-31185https://curecurrent.com/trials/health-literacy-in-understanding-radiation-therapy-information-in-patients-undergoing-definitive-radiation-therapy-31186https://curecurrent.com/trials/the-effect-of-appropriate-family-companionship-on-the-physical-and-mental-health-of-patients-with-advanced-breast-cancer-31187https://curecurrent.com/trials/study-of-tt-00420-tinengotinib-tablet-as-monotherapy-and-combination-therapy-in-patients-with-advanced-solid-tumors-31188https://curecurrent.com/trials/the-treatment-of-stage-i-and-ii-carcinoma-of-the-breast-with-mastectomy-and-axillary-dissection-versus-excisional-biopsy-31189https://curecurrent.com/trials/the-mamma-hitop-study-31190https://curecurrent.com/trials/utidelone-utd1-plus-capecitabine-in-non-pcr-tnbc-after-neoadjuvant-therapy-31191https://curecurrent.com/trials/self-applied-acupressure-for-arthralgia-fatigue-sleep-disturbance-in-breast-cancer-31192https://curecurrent.com/trials/vr-for-surgical-prehabilitation-and-rehabilitation-31193https://curecurrent.com/trials/safety-tolerability-and-efficacy-study-in-subjects-with-advanced-or-metastatic-breast-cancer-31194https://curecurrent.com/trials/study-of-cabozantinib-xl184-in-adults-with-advanced-malignancies-31195https://curecurrent.com/trials/cancer-related-fatigue-in-patients-with-breast-cancer-treatment-with-zhengyuan-capsules-31196https://curecurrent.com/trials/study-of-68ga-131i-sgmib-zt-199-pet-imaging-targeting-her2-positive-in-the-diagnosis-of-metastatic-breast-cancer-31197https://curecurrent.com/trials/a-first-in-human-study-of-son-dp-in-participants-with-relapsed-refractory-intolerant-to-standard-of-care-therapies-for-a-31198https://curecurrent.com/trials/new-model-for-integrating-person-based-care-pbc-in-the-treatment-of-advanced-her2-negative-breast-cancer-31199https://curecurrent.com/trials/factors-influencing-breast-cancer-resection-volumes-and-their-impact-on-treatment-outcome-fibratio-31200https://curecurrent.com/trials/estrogen-receptors-and-her2-levels-expression-in-luminal-metastatic-breast-cancer-31201https://curecurrent.com/trials/surgical-skill-labs-for-robotic-mastectomy-and-educational-program-using-a-surgical-guide-by-artificial-intelligence-31202https://curecurrent.com/trials/lyt-100-in-patients-with-bcrl-31203https://curecurrent.com/trials/higher-dose-preoperative-tamoxifen-in-premenopausal-breast-cancer-patients-31204https://curecurrent.com/trials/a-multicenter-double-blind-randomized-parallel-group-phase-iii-study-of-the-efficacy-and-safety-of-ql1701-plus-docetaxel-31205https://curecurrent.com/trials/a-phase-ib-study-of-ntq1062-in-combination-with-fulvestrant-in-patients-with-advanced-hr-positive-her-2-negative-breast-31206https://curecurrent.com/trials/patient-reported-outcomes-study-using-electronic-monitoring-system-for-advanced-or-metastatic-solid-cancer-31207https://curecurrent.com/trials/prs-343-in-combination-with-atezolizumab-in-her2-positive-solid-tumors-31208https://curecurrent.com/trials/prs-343-in-her2-positive-solid-tumors-31209https://curecurrent.com/trials/randomized-study-versus-placebo-for-the-prevention-of-neurotoxicity-induced-by-weekly-paclitaxel-31210https://curecurrent.com/trials/my-surgical-success-a-randomized-controlled-pilot-study-of-a-pre-surgical-psychological-intervention-31211https://curecurrent.com/trials/barriers-associated-with-timely-adjuvant-chemotherapy-administration-in-patients-with-invasive-breast-cancer-31212https://curecurrent.com/trials/team-based-psychosocial-care-to-promote-maintain-and-restore-wellness-of-breast-cancer-patients-31213https://curecurrent.com/trials/fluorescence-guided-surgery-in-breast-cancer-the-margin-2-study-31214https://curecurrent.com/trials/web-based-screening-and-tailored-support-31215https://curecurrent.com/trials/exercise-interventions-for-improving-health-in-breast-cancer-survivors-31216https://curecurrent.com/trials/evaluation-of-a-physical-activity-program-in-overweight-breast-cancer-patients-31217https://curecurrent.com/trials/study-in-participants-with-early-stage-or-locally-advanced-human-epidermal-growth-factor-receptor-her-2-positive-and-est-31218https://curecurrent.com/trials/a-multicenter-clinical-study-of-apatinib-mesylate-combined-with-doctor-s-choice-for-advanced-breast-cancer-31219https://curecurrent.com/trials/the-effect-of-foot-massage-with-roles-on-cancer-patients-31220https://curecurrent.com/trials/study-of-palbociclib-and-trastuzumab-with-endocrine-therapy-in-her2-positive-metastatic-breast-cancer-31221https://curecurrent.com/trials/study-on-skin-toxicities-induced-by-cancer-treatments-31222https://curecurrent.com/trials/metronomic-chemotherapy-in-a-real-world-population-of-advanced-breast-cancer-patients-31223https://curecurrent.com/trials/pre-pectoral-tissue-expander-and-acellular-dermal-matrix-for-a-two-stage-muscle-sparing-breast-reconstruction-31224https://curecurrent.com/trials/the-effect-of-hand-exercises-on-upper-limb-volume-quality-of-life-and-hand-function-in-breast-cancer-survivors-31225https://curecurrent.com/trials/mr-correlated-spectroscopic-imaging-for-diagnosing-breast-cancer-31226https://curecurrent.com/trials/vacuum-assisted-biopsy-and-surgery-correlation-in-her2-and-tn-breast-cancer-subtypes-mri-responders-after-neoadjuvant-th-31227https://curecurrent.com/trials/breast-cancer-in-pregnancy-register-study-31228https://curecurrent.com/trials/study-to-compare-neoadjuvant-combination-of-trastuzumab-and-pertuzumab-with-concurrent-taxane-chemotherapy-or-endocrine-31229https://curecurrent.com/trials/paced-digitized-support-during-adjuvant-endocrine-therapy-31230https://curecurrent.com/trials/the-prediction-model-of-nac-response-for-breast-cancer-based-on-the-parametric-dynamics-features-31231https://curecurrent.com/trials/study-on-early-auxiliary-diagnosis-and-postoperative-recurrence-monitoring-of-breast-cancer-31232https://curecurrent.com/trials/a-randomized-trial-of-chemotherapy-in-surgical-patients-with-infiltrating-ductal-carcinoma-of-breast-31233https://curecurrent.com/trials/digital-health-intervention-to-improve-health-care-and-outcomes-for-breast-cancer-patients-31234https://curecurrent.com/trials/trial-for-treatment-of-high-risk-bc-with-two-sequences-of-neoadjuvant-chemotherapy-with-pembrolizumab-31235https://curecurrent.com/trials/neoadjuvant-study-with-pyrotinib-and-trastuzumab-and-abraxane-in-patients-with-her2-enriched-breast-cancer-31236https://curecurrent.com/trials/characteristics-and-predictors-of-liver-injury-in-cyclin-dependent-kinase-inhibitors-4-6-cdk4-6-treated-patients-with-ad-31237https://curecurrent.com/trials/trastuzumab-emtansine-t-dm1-in-her2-positive-breast-cancer-patients-with-progressive-disease-after-tkis-or-hp-therapy-31238https://curecurrent.com/trials/implementation-of-the-families-accelerating-cascade-testing-toolkit-factt-for-hereditary-breast-and-ovarian-cancer-and-l-31239https://curecurrent.com/trials/feasibility-of-lifestyle-intervention-in-brca1-2-mutation-carriers-31240https://curecurrent.com/trials/registry-for-intra-operative-radiotherapy-during-breast-conserving-surgery-in-patients-with-early-stage-breast-cancer-31241https://curecurrent.com/trials/a-study-of-camrelizumab-in-combination-with-chemotherapy-regimen-comparative-chemotherapy-regimen-for-metastatic-triple-31242https://curecurrent.com/trials/study-to-evaluate-safety-and-efficacy-of-tj107-combine-with-pd-1-in-patients-with-solid-tumors-31243https://curecurrent.com/trials/getting-back-on-track-an-educational-group-for-women-with-breast-cancer-31244https://curecurrent.com/trials/trastuzumab-deruxtecan-t-dxd-tailoring-treatment-and-companion-diagnostics-cdx-by-liquid-biopsy-31245https://curecurrent.com/trials/breast-and-cervical-cancer-education-program-31246https://curecurrent.com/trials/dwi-in-assessing-treatment-response-in-patients-with-breast-cancer-receiving-neoadjuvant-chemotherapy-31247https://curecurrent.com/trials/plasma-metabolic-biomarkers-for-multi-cancer-diagnosis-31248https://curecurrent.com/trials/adebrelimab-combined-with-dalpiciclib-and-standard-endocrine-therapy-for-hr-her2-advanced-breast-cancer-31249https://curecurrent.com/trials/diagnostic-performance-of-breast-cancer-screening-second-reading-process-assisted-by-ai-31250https://curecurrent.com/trials/shr-a1811-combined-with-bevacizumab-in-her2-positive-breast-cancer-with-brain-metastases-31251https://curecurrent.com/trials/a-multicenter-prospective-study-of-diarrhea-tolerance-of-pyrotinib-combined-with-trastumab-and-taxane-in-the-first-line-31252https://curecurrent.com/trials/endocrine-disruptors-and-life-stile-in-breast-cancer-development-31253https://curecurrent.com/trials/clinical-study-of-personalized-chemotherapy-for-breast-cancer-with-low-doses-of-cyclophosphamide-31254https://curecurrent.com/trials/assessment-for-long-term-cardiovascular-impairment-associated-with-trastuzumab-cardiotoxicity-in-her2-positive-breast-ca-31255https://curecurrent.com/trials/assessing-functional-status-needs-via-pro-measures-for-pts-with-metastatic-breast-cancer-31256https://curecurrent.com/trials/neoadjuvant-phase-ii-study-of-pembrolizumab-and-carboplatin-plus-docetaxel-in-triple-negative-breast-cancer-31257https://curecurrent.com/trials/effect-of-seated-exercises-and-psychoeducational-rehabilitation-on-fatigue-and-coping-of-women-postmastectomy-31258https://curecurrent.com/trials/prehabilitation-exercise-program-in-breast-cancer-effects-on-quality-of-life-and-tumor-microenvironment-pep-bc-31259https://curecurrent.com/trials/efficacy-of-lifestyle-intervention-in-brca1-2-mutation-carriers-31260https://curecurrent.com/trials/impact-of-nipple-micropigmentation-in-mastectomized-women-31261https://curecurrent.com/trials/the-role-of-68ga-dotatate-pet-ct-in-breast-cancer-imaging-31262https://curecurrent.com/trials/treatment-of-breast-fibroadenoma-with-high-intensity-focused-ultrasound-hifu-31263https://curecurrent.com/trials/breast-recovery-after-axillary-node-clearance-evaluating-limbs-with-e-technology-the-bracelet-study-31264https://curecurrent.com/trials/cardioprotective-effect-of-acute-exercise-in-breast-cancer-patients-31265https://curecurrent.com/trials/a-phase-i-ii-multicenter-open-label-study-of-lu-177-dotaga-iac-for-the-treatment-of-angiogenic-breast-cancer-patients-31266https://curecurrent.com/trials/differential-expression-and-potential-value-of-c-myc-in-non-invasive-and-invasive-mammary-carcinoma-31267https://curecurrent.com/trials/real-world-effectiveness-and-safety-study-of-sacituzumab-govitecan-in-chinese-metastatic-breast-cancer-31268https://curecurrent.com/trials/chemotherapy-omission-in-er-her2-breast-cancer-with-1-3-positive-lymph-nodes-receiving-extended-adjuvant-abemaciclib-31269https://curecurrent.com/trials/association-of-snps-in-long-intergenic-noncoding-rna-00511-linc00511-with-breast-cancer-among-the-egyptian-population-31270https://curecurrent.com/trials/biopsychosocial-approach-of-the-cancer-related-fatigue-biocare-factory-31271https://curecurrent.com/trials/a-study-to-evaluate-the-efficacy-and-safety-in-subjects-with-advanced-breast-cancer-treated-with-syhx2011-31272https://curecurrent.com/trials/iv-dexmedetomidine-vs-oral-gabapentin-and-their-combination-for-postoperative-analgesia-in-cancer-patients-undergoing-mo-31273https://curecurrent.com/trials/study-to-assess-the-impact-of-personalized-coaching-on-the-time-period-and-quality-of-return-to-work-after-breast-cancer-31274https://curecurrent.com/trials/dnx-2440-for-resectable-colorectal-liver-metastasis-31275https://curecurrent.com/trials/hypofractionated-vs-standard-radiotherapy-in-breast-cancer-with-an-indication-for-regional-lymph-node-irradiation-about-31276https://curecurrent.com/trials/ultrasound-in-detecting-taxane-induced-neuropathy-in-patients-with-breast-cancer-31277https://curecurrent.com/trials/clinical-trial-of-neoadjuvant-chemotherapy-with-atezolizumab-or-placebo-in-patients-with-triple-negative-breast-cancer-f-31278https://curecurrent.com/trials/energy-balance-and-breast-cancer-aspects-ii-31279https://curecurrent.com/trials/breaststroke-swimming-after-breast-cancer-treatment-surgery-as-a-means-of-treatment-for-seroma-lymphedema-and-chronic-ar-31280https://curecurrent.com/trials/evaluate-impact-of-exercise-program-on-fatigue-in-breast-cancer-during-chemotherapy-31281https://curecurrent.com/trials/a-study-of-the-cd73-inhibitor-ly3475070-alone-or-in-combination-with-pembrolizumab-in-participants-with-advanced-cancer-31282https://curecurrent.com/trials/fluorestradiol-fes-pet-ct-for-imaging-estrogen-receptor-status-31283https://curecurrent.com/trials/new-digital-person-based-care-model-in-patients-with-her2-negative-advanced-breast-cancer-31284https://curecurrent.com/trials/multimodal-assesment-of-acute-cardiac-toxicity-induced-by-thoracic-radiotherapy-in-cancer-patients-31285https://curecurrent.com/trials/mapping-arterial-perforators-within-the-breast-during-mammoplasty-31286https://curecurrent.com/trials/palbociclib-pd-0332991-combined-with-fulvestrant-in-hormone-receptor-her2-negative-metastatic-breast-cancer-after-endocr-31287https://curecurrent.com/trials/evaluate-the-effectiveness-and-toxicity-of-adjuvant-ultra-hypofractionated-radiotherapy-for-breast-cancer-31288https://curecurrent.com/trials/her2-directed-biosimilar-in-breast-cancer-real-world-epro-31289https://curecurrent.com/trials/radiologic-evaluation-and-breast-density-read-31290https://curecurrent.com/trials/breast-cancer-antiestrogenic-therapy-brain-31291https://curecurrent.com/trials/metabolic-flexibility-and-autonomic-control-after-muscle-power-vs-metabolic-power-training-in-postmenopausal-oncological-31292https://curecurrent.com/trials/vaginal-dilator-therapy-among-women-with-gynecologic-and-breast-cancers-experiencing-dyspareunia-31293https://curecurrent.com/trials/increasing-access-to-breast-cancer-screening-among-immigrants-31294https://curecurrent.com/trials/a-pre-surgical-pk-study-of-im-and-intraductally-delivered-fulvestrant-31295https://curecurrent.com/trials/balugrastim-neugranin-in-breast-cancer-participants-receiving-doxorubicin-docetaxel-31296https://curecurrent.com/trials/whole-genome-sequencing-in-breast-cancer-31297https://curecurrent.com/trials/platelet-rich-plasma-for-the-treatment-of-genitourinary-syndrome-of-menopause-in-patients-with-stage-0-iii-breast-cancer-31298https://curecurrent.com/trials/evaluation-of-a-novel-axillary-lymph-node-ink-localization-technique-a-feasibility-study-31299https://curecurrent.com/trials/prospective-evaluation-of-ai-r-d-tool-for-patient-stratification-moa-evaluation-in-triple-negative-breast-cancer-pear-me-31300https://curecurrent.com/trials/potential-protective-role-of-sglt-2-inhibitors-for-chemotherapy-induced-cardiotoxicity-31301https://curecurrent.com/trials/efficacy-and-safety-of-dalpiciclib-with-endocrine-therapy-as-adjuvant-treatment-in-hr-her2-early-breast-cancer-31302https://curecurrent.com/trials/exercise-and-diet-counseling-program-in-improving-quality-of-life-in-stage-i-iii-breast-cancer-survivors-31303https://curecurrent.com/trials/a-study-of-abemaciclib-ly2835219-with-and-without-food-in-participants-with-metastatic-breast-cancer-31304https://curecurrent.com/trials/a-qualitative-study-on-treatment-adherence-in-patients-with-metastatic-breast-cancer-31305https://curecurrent.com/trials/a-real-world-efficacy-and-safety-study-of-amlotinib-for-her2-negative-advanced-breast-cancer-31306https://curecurrent.com/trials/study-of-ngm438-as-monotherapy-and-in-combination-with-pembrolizumab-in-advanced-or-metastatic-solid-tumors-31307https://curecurrent.com/trials/nt-probnp-to-assess-trastuzumab-induced-cardiotoxicity-31308https://curecurrent.com/trials/italian-validation-of-a-tool-for-assessing-sexual-function-after-breast-cancer-fsfi-bc-31309https://curecurrent.com/trials/chemotherapy-induced-peripheral-neuropathy-cipn-on-motor-and-sensory-function-31310https://curecurrent.com/trials/serratus-plane-block-versus-serratus-plane-block-plus-parasternal-block-combination-for-breast-surgery-31311https://curecurrent.com/trials/trotabresib-in-combination-with-vinorelbine-and-radiation-therapy-for-the-treatment-of-her2-breast-cancer-with-central-n-31312https://curecurrent.com/trials/i-ii-phase-study-evaluating-m1774-in-combination-with-fulvestrant-in-hr-and-her2-advanced-breast-cancers-31313https://curecurrent.com/trials/effects-of-aromatherapy-on-patients-undergoing-chemotherapy-for-breast-cancer-31314https://curecurrent.com/trials/evaluating-the-incidence-of-pseudo-acute-kidney-injuries-in-patients-with-metastatic-breast-cancer-on-cdk4-6-inhibitors-31315https://curecurrent.com/trials/dose-escalation-study-morab-066-targeting-tissue-factor-tf-expressing-malignancies-including-breast-pancreatic-colorecta-31316https://curecurrent.com/trials/neoadjuvant-chemotherapy-in-her2-positive-breast-cancer-train-2-31317https://curecurrent.com/trials/palbociclib-in-metastatic-breast-cancer-gene-polymorphism-based-study-in-egyptian-patients-31318https://curecurrent.com/trials/a-study-of-cdx-1140-cd40-as-monotherapy-or-in-combination-in-patients-with-advanced-malignancies-31319https://curecurrent.com/trials/implementing-exercise-into-clinical-practice-in-breast-cancer-care-31320https://curecurrent.com/trials/cardiocare-prospective-clinical-study-31321https://curecurrent.com/trials/surgical-and-patient-reported-outcomes-in-robotic-mastectomy-31322https://curecurrent.com/trials/a-study-of-ipatasertib-in-combination-with-atezolizumab-and-paclitaxel-as-a-treatment-for-participants-with-locally-adva-31323https://curecurrent.com/trials/preferences-and-chemotherapy-in-breast-cancer-patients-31324https://curecurrent.com/trials/effects-of-exemestane-on-bone-strength-31325https://curecurrent.com/trials/a-study-of-camrelizumab-plus-chemotherapy-vs-placebo-plus-chemotherapy-as-neoadjuvant-therapy-in-participants-with-tripl-31326https://curecurrent.com/trials/brain-metastasis-development-mechanism-in-bcbm-patients-31327https://curecurrent.com/trials/a-study-of-atezolizumab-and-paclitaxel-versus-placebo-and-paclitaxel-in-participants-with-previously-untreated-locally-a-31328https://curecurrent.com/trials/the-resistance-mechanism-of-trastuzumab-deruxtexan-in-her2-positive-breast-cancer-patients-31329https://curecurrent.com/trials/fh-risk-2-0-updating-breast-cancer-risk-estimates-31330https://curecurrent.com/trials/pulsed-electromagnetic-fields-for-analgesia-post-mastectomy-31331https://curecurrent.com/trials/reoperative-sentinel-lymph-node-biopsy-in-patients-with-recurrent-ipsilateral-breast-cancer-31332https://curecurrent.com/trials/asian-multicenter-prospective-study-in-her2-positive-early-breast-cancer-for-detecting-mrd-by-ctdna-harmony-study-31333https://curecurrent.com/trials/effect-of-complex-decongestive-therapy-cryotherapy-and-kinesio-taping-in-patients-with-post-mastectomy-lymphedema-a-rand-31334https://curecurrent.com/trials/pro-survivorship-concerns-ita-31335https://curecurrent.com/trials/psychosexuological-interventions-to-support-sexual-function-in-breast-cancer-patients-31336https://curecurrent.com/trials/hcq-adc-vs-adc-in-the-treatment-of-advanced-breast-cancer-31337https://curecurrent.com/trials/multidisciplinary-approach-to-breast-cancer-through-the-study-of-altered-transcriptomic-and-immune-accompanied-by-the-id-31338https://curecurrent.com/trials/window-of-opportunity-trial-of-entinostat-in-patients-with-newly-diagnosed-stage-i-iiic-tnbc-31339https://curecurrent.com/trials/adjuvant-pyrotinib-and-capecitabine-for-her2-positive-micro-invasive-breast-cancer-31340https://curecurrent.com/trials/a-study-of-py314-in-subjects-with-advanced-solid-tumors-31341https://curecurrent.com/trials/a-phase-1a-1b-fih-study-of-py159-and-in-combination-with-pembrolizumab-in-subjects-with-advanced-solid-tumors-31342https://curecurrent.com/trials/study-of-astx727-plus-talazoparib-in-patients-with-triple-negative-or-hormone-resistant-her2-negative-metastatic-breast-31343https://curecurrent.com/trials/palbociclib-plus-tamoxifen-for-the-treatment-of-hormone-receptor-positive-her2-negative-advanced-breast-cancer-women-asi-31344https://curecurrent.com/trials/exercise-gut-microbiome-and-breast-cancer-increasing-reach-to-underserved-populations-31345https://curecurrent.com/trials/letrozole-in-treating-postmenopausal-women-who-have-received-hormone-therapy-for-hormone-receptor-positive-breast-cancer-31346https://curecurrent.com/trials/analgesic-efficacy-of-u-s-retrolaminar-block-and-erector-spinae-plane-block-in-mrm-31347https://curecurrent.com/trials/hypofractionation-with-simultaneous-integrated-boost-vs-standard-fractionation-in-early-breast-cancer-31348https://curecurrent.com/trials/electroacupuncture-plus-antiemetic-therapy-for-chemotherapy-induced-nausea-and-vomiting-in-patients-with-breast-cancer-31349https://curecurrent.com/trials/fertility-changes-due-to-cancer-an-investigation-of-meaning-psychological-distress-and-psychologi-31350https://curecurrent.com/trials/study-of-cyh33-in-combination-with-olaparib-an-oral-parp-inhibitor-in-patients-with-advanced-solid-tumors-31351https://curecurrent.com/trials/gm103-intratumoral-injection-in-patients-with-locally-advanced-unresectable-refractory-and-or-metastatic-solid-tumors-31352https://curecurrent.com/trials/reoperation-rate-in-breast-conserving-surgery-using-confocal-histolog-scanner-for-intraoperative-margin-assessment-31353https://curecurrent.com/trials/combination-chemotherapy-in-treating-women-with-stage-i-stage-ii-or-stage-iiia-ct1-3-n0-1-m0-breast-cancer-and-positive-31354https://curecurrent.com/trials/alternative-dosing-schedule-of-palbociclib-in-metastatic-hormone-receptor-positive-breast-cancer-31355https://curecurrent.com/trials/feasibility-of-an-evidence-based-walking-program-in-cancer-pts-60-during-chemotherapy-31356https://curecurrent.com/trials/study-for-the-multidimensional-analyses-of-resistance-and-toxicity-to-immune-and-targeted-therapies-31357https://curecurrent.com/trials/lymphedema-evaluation-after-adjuvant-hypofractionated-radiotherapy-for-1-2-macrometastatic-sentinel-lymph-nodes-31358https://curecurrent.com/trials/olaparib-and-alpelisib-for-treatment-of-metastatic-breast-cancer-a-combomatch-treatment-trial-31359https://curecurrent.com/trials/improving-the-quality-of-radiotherapy-by-multi-institution-knowledge-based-planning-optimization-models-acronym-mikapoco-31360https://curecurrent.com/trials/response-evaluation-of-cancer-therapeutics-in-metastatic-breast-cancer-to-the-bone-31361https://curecurrent.com/trials/reduced-dose-of-pegfilgrastim-as-support-for-chemotherapy-for-breast-cancer-31362https://curecurrent.com/trials/pembrolizumab-and-doxorubicin-hydrochloride-or-anti-estrogen-therapy-in-treating-patients-with-triple-negative-or-hormon-31363https://curecurrent.com/trials/minimal-access-versus-conventional-latissimus-dorsi-flap-harvest-for-breast-reconstruction-31364https://curecurrent.com/trials/timing-of-surgery-and-the-evolution-of-postoperative-outcomes-in-breast-cancer-patients-undergoing-surgical-intervention-31365https://curecurrent.com/trials/neoadjuvant-study-of-dv-in-combination-toripalimab-or-sequence-chemotherapy-in-hr-negative-her2-low-expressing-breast-ca-31366https://curecurrent.com/trials/can-ilr-reduce-the-risk-of-arm-lymphedema-31367https://curecurrent.com/trials/study-of-the-effects-of-transcutaneous-vagus-nerve-stimulation-on-cancer-patients-31368https://curecurrent.com/trials/barriers-to-screening-breast-mri-utilization-among-patients-at-elevated-risk-31369https://curecurrent.com/trials/nurse-led-physical-activity-program-among-breast-cancer-survivors-31370https://curecurrent.com/trials/breast-cancer-subtype-characterization-through-patient-s-derived-organoids-31371https://curecurrent.com/trials/tamoxifen-versus-anastrozole-alone-or-in-combination-with-zoledronic-acid-31372https://curecurrent.com/trials/neoadjuvant-radiotherapy-for-breast-cancer-31373https://curecurrent.com/trials/assessing-the-clinical-utility-of-adding-pentoxifylline-to-neoadjuvant-chemotherapy-protocols-in-breast-cancer-patients-31374https://curecurrent.com/trials/amh-predicts-postchemotherapy-menopause-in-premenopausal-breast-cancer-patients-31375https://curecurrent.com/trials/study-of-capecitabine-combined-with-camrelizumab-for-non-pcr-tnbc-with-tls-after-neoadjuvant-chemoterapy-31376https://curecurrent.com/trials/european-real-world-experience-of-previously-treated-advanced-metastatic-her2-positive-breast-cancer-patients-accessing-31377https://curecurrent.com/trials/a-multi-modality-imaging-assessment-of-chemobrain-31378https://curecurrent.com/trials/cinpt-in-autologous-diep-flap-breast-reconstruction-31379https://curecurrent.com/trials/the-effect-of-web-assisted-peer-education-for-early-diagnosis-of-breast-cancer-on-health-beliefs-knowledge-levels-and-br-31380https://curecurrent.com/trials/a-study-of-poziotinib-in-patients-with-epidermal-growth-factor-receptor-egfr-or-human-epidermal-growth-factor-receptor-2-31381https://curecurrent.com/trials/a-pk-study-to-assess-the-drug-drug-interaction-of-a-bcrp-inhibitor-on-adagrasib-31382https://curecurrent.com/trials/bc-risk-assessment-before-top-surgery-31383https://curecurrent.com/trials/eribulin-combined-with-sintilimab-as-first-line-treatment-for-unresectable-locally-advanced-or-metastatic-her2-negative-31384https://curecurrent.com/trials/carbonic-anhydrase-ix-enzyme-in-triple-negative-breast-carcinoma-31385https://curecurrent.com/trials/artiss-a-single-centre-randomised-control-study-31386https://curecurrent.com/trials/axillary-management-after-neoadjuvant-chemotherapy-31387https://curecurrent.com/trials/prediction-of-response-to-2nd-line-hormone-therapy-by-fes-ct-pet-in-patients-with-metastatic-breast-cancer-31388https://curecurrent.com/trials/dexamethasone-versus-dexmedetomidine-as-adjuncts-to-serratus-anterior-plane-block-31389https://curecurrent.com/trials/a-study-of-tqb2930-for-injection-monotherapy-or-combination-therapy-in-patients-with-recurrent-metastatic-breast-cancer-31390https://curecurrent.com/trials/real-world-study-of-inetetamab-in-her2-positive-metastatic-breast-cancer-31391https://curecurrent.com/trials/co2-laser-therapy-for-the-treatment-of-gsm-in-patients-with-breast-cancer-31392https://curecurrent.com/trials/a-study-of-ipatasertib-in-combination-with-paclitaxel-as-a-treatment-for-participants-with-pik3ca-akt1-pten-altered-loca-31393https://curecurrent.com/trials/trilaciclib-a-cdk4-6-inhibitor-in-patients-with-early-stage-triple-negative-breast-cancer-31394https://curecurrent.com/trials/supine-mri-in-breast-cancer-patients-undergoing-upfront-surgery-or-receiving-neoadjuvant-therapy-31395https://curecurrent.com/trials/dalpiciclib-with-endocrine-therapy-for-advanced-breast-cancer-after-cdk4-6-inhibitor-failure-dawna-fes-31396https://curecurrent.com/trials/precision-therapy-for-solid-tumors-synergistic-cdk4-6-inhibition-and-anti-vegf-targeting-lncrna-31397https://curecurrent.com/trials/study-of-efficacy-and-safety-in-premenopausal-women-with-hormone-receptor-positive-her2-negative-advanced-breast-cancer-31398https://curecurrent.com/trials/paclitaxel-plus-pembrolizumab-vs-paclitaxel-weekly-in-er-luminal-b-metastatic-breast-cancer-31399https://curecurrent.com/trials/basket-study-of-neratinib-in-participants-with-solid-tumors-harboring-somatic-her2-or-egfr-exon-18-mutations-31400https://curecurrent.com/trials/trial-of-kn026-in-patients-with-her2-positive-advanced-malignant-breast-cancer-and-gastric-cancer-31401https://curecurrent.com/trials/non-viral-tcr-gene-therapy-31402https://curecurrent.com/trials/evaluation-of-hydroxychloroquine-to-prevent-cipn-31403https://curecurrent.com/trials/a-safety-and-tolerability-study-of-nc318-in-subjects-with-advanced-or-metastatic-solid-tumors-31404https://curecurrent.com/trials/lapatinib-and-tamoxifen-in-treating-patients-with-advanced-or-metastatic-breast-cancer-31405https://curecurrent.com/trials/phase-ii-study-of-gtx024-in-women-with-metastatic-breast-cancer-31406https://curecurrent.com/trials/pilot-study-of-the-ehealth-application-cancer-patients-better-life-experience-capable-italy-31407https://curecurrent.com/trials/locoregional-recurrence-after-neoadjuvant-versus-adjuvant-chemotherapy-31408https://curecurrent.com/trials/hr-her2-advanced-breast-cancer-and-endocrine-resistance-31409https://curecurrent.com/trials/cardiac-rehabilitation-for-breast-cancer-survivors-31410https://curecurrent.com/trials/effects-of-diet-and-osteopathy-on-quality-of-life-and-inflammation-in-breast-cancer-patients-under-hormonal-therapy-31411https://curecurrent.com/trials/stereotactic-radiation-therapy-for-he2-positive-oligometastatic-breast-cancer-31412https://curecurrent.com/trials/a-study-of-hc-5404-fu-to-establish-the-maximum-tolerated-dose-mtd-31413https://curecurrent.com/trials/implant-based-breast-reconstruction-and-mastectomy-with-fat-grafting-after-breast-conserving-surgery-and-radiotherapy-31414https://curecurrent.com/trials/combination-chemotherapy-with-trastuzumab-in-treating-women-with-metastatic-breast-cancer-31415https://curecurrent.com/trials/sorafenib-in-treating-patients-with-metastatic-breast-cancer-31416https://curecurrent.com/trials/neoadjuvant-chemotherapy-with-nab-paclitaxel-in-women-with-her2-negative-high-risk-breast-cancer-31417https://curecurrent.com/trials/study-of-intratumorally-administered-stimulator-of-interferon-genes-sting-agonist-e7766-in-participants-with-advanced-so-31418https://curecurrent.com/trials/myeloprotection-with-trilaciclib-in-pan-cancer-population-31419https://curecurrent.com/trials/mcla-128-with-trastuzumab-chemotherapy-in-her2-and-with-endocrine-therapy-in-er-and-low-her2-breast-cancer-31420https://curecurrent.com/trials/neoadjuvant-therapy-in-triple-negative-breast-cancer-with-antipdl1-31421https://curecurrent.com/trials/a-randomized-phase-ii-study-of-eribulin-mesylate-with-or-without-pembrolizumab-for-metastatic-hormone-receptor-positive-31422https://curecurrent.com/trials/a-european-registry-study-to-prospectively-observe-treatment-patterns-and-outcomes-in-participants-with-human-epidermal-31423https://curecurrent.com/trials/care-coordination-for-complex-cancer-survivors-in-an-integrated-safety-net-system-31424https://curecurrent.com/trials/snaps-breast-cancer-patient-study-breast-cancer-patients-31425https://curecurrent.com/trials/ehealth-interventions-for-breast-cancer-cognitive-impairment-31426https://curecurrent.com/trials/serratus-anterior-plane-block-for-modified-radical-mastectomy-double-point-vs-single-point-31427https://curecurrent.com/trials/the-marvin-chatbots-to-provide-information-for-different-health-conditions-31428https://curecurrent.com/trials/study-of-prediction-of-ovarian-reserve-in-yong-breast-cancer-patients-treated-with-chemotherapy-31429https://curecurrent.com/trials/study-evaluating-hemay022-in-combination-with-endocrine-therapy-in-subjects-with-er-positive-and-her2-positive-advanced-31430https://curecurrent.com/trials/online-psychosocial-cancer-screening-monitoring-and-stepped-treatment-in-cancer-survivors-31431https://curecurrent.com/trials/neoadjuvant-treatment-of-her2-positive-early-high-risk-and-locally-advanced-breast-cancer-31432https://curecurrent.com/trials/the-effectiveness-of-hemopatch-in-the-reduction-of-post-surgical-serous-drainage-31433https://curecurrent.com/trials/spa-therapy-for-upper-or-lower-limb-lymphoedema-31434https://curecurrent.com/trials/investigating-the-value-of-early-sleep-therapy-31435https://curecurrent.com/trials/lymphaticovenous-anastomosis-as-treatment-for-lymphedema-31436https://curecurrent.com/trials/nutritional-intervention-and-dna-damage-of-patients-with-hboc-31437https://curecurrent.com/trials/palbociclib-in-estrogen-receptor-positive-er-human-epidermal-growth-factor-receptor-2-positive-her2-metastatic-breast-ca-31438https://curecurrent.com/trials/study-of-gx-i7-in-combination-with-pembrolizumab-in-refractory-or-relapsed-r-r-tnbc-subjects-gx-i7-ca-006-keynote-899-31439https://curecurrent.com/trials/compare-the-efficacy-of-surgery-combined-with-systemic-therapy-and-pure-systemic-therapy-in-breast-cancer-patients-31440https://curecurrent.com/trials/clinical-study-on-pharmacokinetics-of-fcn-437c-capsule-and-its-effect-on-qt-interval-in-healthy-subjects-31441https://curecurrent.com/trials/a-study-of-trastuzumab-emtansine-t-dm1-plus-pertuzumab-pertuzumab-placebo-versus-trastuzumab-herceptin-plus-a-taxane-in-31442https://curecurrent.com/trials/serial-measurements-of-molecular-and-architectural-responses-to-therapy-smmart-prime-trial-31443https://curecurrent.com/trials/vaccine-therapy-in-treating-patients-with-metastatic-cancer-31444https://curecurrent.com/trials/multidisciplinary-care-pathway-with-electronic-patient-reported-outcomes-epro-post-operative-follow-up-of-breast-cancer-31445https://curecurrent.com/trials/microwave-ablation-in-the-treatment-of-early-stage-unifocal-invasive-breast-cancer-31446https://curecurrent.com/trials/real-life-pilot-feasibility-study-lc-rlp-31447https://curecurrent.com/trials/a-retrospective-non-interventional-study-of-breast-cancer-patients-diagnosed-with-hr-her2-locally-advanced-or-metastatic-31448https://curecurrent.com/trials/evaluating-the-efficacy-and-safety-of-bevacizumab-carboplatin-gemcitabine-and-atezolizumab-in-breast-cancer-31449https://curecurrent.com/trials/study-evaluating-hemay022-in-subjects-with-her2-positive-advanced-breast-cancer-31450https://curecurrent.com/trials/early-rehabilitation-of-cancer-patients-31451https://curecurrent.com/trials/a-comparison-of-the-15-and-30-acquisition-angle-breast-tomosynthesis-mammography-for-breast-abnormalities-31452https://curecurrent.com/trials/prospective-comparison-of-breast-mri-vs-contrast-mammography-prior-to-surgery-in-breast-cancer-patients-31453https://curecurrent.com/trials/ai-assisted-system-for-accurate-diagnosis-and-prognosis-of-breast-phyllodes-tumors-31454https://curecurrent.com/trials/unilateral-secondary-breast-reconstruction-using-a-muscle-sparing-pedicled-dorsal-flap-after-breast-cancer-31455https://curecurrent.com/trials/evaluation-of-the-impact-of-a-multidimensional-ict-intervention-on-the-quality-of-life-of-breast-cancer-survivors-31456https://curecurrent.com/trials/toxicity-after-radiotherapy-in-breast-cancer-survivors-thoraces-a-retrospective-cohort-study-31457https://curecurrent.com/trials/the-effect-of-mobile-health-application-on-posttraumatic-growth-in-women-diagnosed-with-breast-cancer-31458https://curecurrent.com/trials/stockholm-mammography-risk-stratified-trial-31459https://curecurrent.com/trials/stress-reducing-intervention-in-patients-with-colorectal-and-breast-cancer-31460https://curecurrent.com/trials/a-guided-online-intervention-to-improve-quality-of-life-in-breast-cancer-patients-a-randomised-clinical-trial-31461https://curecurrent.com/trials/early-prediction-and-warning-for-cardiotoxicity-due-to-anthracycline-based-breast-cancer-chemotherapy-31462https://curecurrent.com/trials/possible-protective-effect-of-rosuvastatin-in-chemotherapy-induced-cardiotoxicity-in-her2-positive-breast-cancer-patient-31463https://curecurrent.com/trials/using-an-end-of-life-conversation-game-to-engage-patients-with-cancer-in-advance-care-planning-31464https://curecurrent.com/trials/the-efficacy-and-safety-of-pyrotinib-trastuzumab-combined-with-taxanes-in-the-treatment-of-trastuzumab-treated-her2-adva-31465https://curecurrent.com/trials/implications-of-medical-low-dose-radiation-exposure-breast-cancer-acute-coronary-events-31466https://curecurrent.com/trials/impact-of-casp3-gene-in-chemoresistance-31467https://curecurrent.com/trials/exercise-program-in-cancer-and-cognition-31468https://curecurrent.com/trials/late-toxicity-in-breast-cancer-patients-treated-with-breast-conserving-surgical-procedures-and-radiotherapy-using-the-si-31469https://curecurrent.com/trials/oncoliq-test-for-early-breast-cancer-detection-31470https://curecurrent.com/trials/axillary-reverse-mapping-in-breast-cancer-31471https://curecurrent.com/trials/ficus-septica-leaves-fraction-as-a-complementary-therapy-for-stadium-iv-breast-cancer-patients-31472https://curecurrent.com/trials/vabb-after-neoadjuvant-therapy-to-avoid-surgery-pcr-to-avoid-breast-surgery-31473https://curecurrent.com/trials/early-detection-of-imaging-derived-subclinical-cardiac-injuries-31474https://curecurrent.com/trials/tops-for-african-american-breast-cancer-survivors-31475https://curecurrent.com/trials/treatment-pleural-carcinosis-of-pressurized-intrathoracic-hyperthermic-aerosol-cisplatin-administration-31476https://curecurrent.com/trials/intrusion-unraveling-the-intratumoral-pk-pd-relation-for-sar408701-31477https://curecurrent.com/trials/carboplatin-nab-paclitaxel-plus-trastuzumab-her2-or-bevacizumab-her2-in-the-neoadjuvant-setting-31478https://curecurrent.com/trials/omission-of-breast-surgery-for-breast-cancer-patients-with-pcr-on-mri-and-vacuum-assisted-biopsy-after-nst-optimist-31479https://curecurrent.com/trials/a-retrospective-analysis-of-magnetic-resonance-imaging-data-for-breast-cancer-screening-in-the-open-consortium-for-decen-31480https://curecurrent.com/trials/intraoperative-imaging-of-lymph-nodes-31481https://curecurrent.com/trials/dedicated-breast-ct-for-diagnosis-of-breast-cancer-31482https://curecurrent.com/trials/dual-anti-her2-therapy-lapatinib-and-trastuzumab-plus-chemotherapy-in-her2-positive-mbc-31483https://curecurrent.com/trials/disitamab-vedotin-pyrotinib-versus-thp-in-the-first-line-treatment-for-her2-advanced-breast-cancer-clinical-trial-31484https://curecurrent.com/trials/different-level-of-ecswt-in-post-mastectomy-lymphedema-31485https://curecurrent.com/trials/500mg-fulvestrant-in-hr-mbc-31486https://curecurrent.com/trials/dalpiciclib-fulvestrant-trastuzumab-and-pertuzumab-in-hr-positive-her2-positive-metastatic-breast-cancer-31487https://curecurrent.com/trials/real-world-study-of-lapatinib-among-metastatic-breast-cancer-patients-31488https://curecurrent.com/trials/understanding-shared-psychobiological-pathways-31489https://curecurrent.com/trials/metronomic-treatment-option-in-advanced-breast-cancer-31490https://curecurrent.com/trials/a-study-comparing-the-efficacy-of-tcbhp-and-echp-thp-in-the-neoadjuvant-treatment-of-her2-positive-breast-cancer-31491https://curecurrent.com/trials/add-on-study-for-protocol-g200802-nct02463032-effect-of-gtx-024-on-maximal-neuromuscular-function-and-lean-body-mass-31492https://curecurrent.com/trials/efficacy-safety-evaluation-of-enobosarm-in-combo-with-abemaciclib-in-treatment-of-er-her2-metastatic-breast-cancer-31493https://curecurrent.com/trials/mammaprint-value-for-pre-menopausal-breast-cancer-patients-31494https://curecurrent.com/trials/study-of-predictors-of-clinical-outcomes-in-patients-with-hr-and-her2-low-negative-breast-cancer-31495https://curecurrent.com/trials/real-world-study-of-utd1-in-chinese-advanced-breast-cancer-31496https://curecurrent.com/trials/detection-and-analysis-of-mbc-with-heterogeneous-er-expression-31497https://curecurrent.com/trials/negative-er-expression-assessed-by-18f-fes-pet-ct-in-the-mbc-with-er-positive-primary-tumor-31498https://curecurrent.com/trials/pyrotinib-plus-trastuzumab-versus-pertuzumab-plus-trastuzumab-31499https://curecurrent.com/trials/study-of-f-627-in-women-with-breast-cancer-receiving-myelotoxic-chemotherapy-31500https://curecurrent.com/trials/physical-exercise-benefits-for-cancer-patients-31501https://curecurrent.com/trials/chemo-free-brca-targeted-neoadjuvant-strategy-31502https://curecurrent.com/trials/visually-impaired-women-model-based-cancer-education-and-breast-self-examination-31503https://curecurrent.com/trials/a-study-of-mitoxantrone-hydrochloride-liposome-injection-in-patients-with-advanced-her2-negative-breast-cancer-31504https://curecurrent.com/trials/combination-therapy-with-myocet-doxorubicin-hcl-liposome-for-injection-in-participants-with-her2-positive-breast-cancer-31505https://curecurrent.com/trials/evaluation-of-the-effect-of-nigella-sativa-for-the-prophylaxis-to-radiation-induced-dermatitis-in-breast-cancer-patients-31506https://curecurrent.com/trials/reducing-neutropenia-incidence-with-pegfilgrastim-administration-on-day-3-after-chemotherapy-31507https://curecurrent.com/trials/vitamin-d-can-increase-pathological-response-of-the-breast-cancer-patients-treated-with-neoadjuvant-therapy-31508https://curecurrent.com/trials/accelerated-hypofractionated-radiotherapy-ahf-rt-for-the-treatment-of-breast-cancer-31509https://curecurrent.com/trials/afimoxifene-in-reducing-the-risk-of-breast-cancer-in-women-with-mammographically-dense-breast-31510https://curecurrent.com/trials/dissecting-the-pathways-of-therapy-resistance-in-early-breast-cancer-31511https://curecurrent.com/trials/effects-of-rehabilitation-and-kinesio-taping-to-prevent-axillary-web-syndrome-after-breast-cancer-surgery-31512https://curecurrent.com/trials/human-epidermal-growth-factor-receptor-2-her2-positive-unresectable-locally-advanced-or-metastatic-breast-cancer-disease-31513https://curecurrent.com/trials/safety-and-efficacy-comparison-of-docetaxel-and-ixabepilone-in-non-metastatic-poor-prognosis-breast-cancer-31514https://curecurrent.com/trials/a-study-of-camrelizumab-plus-chemotherapy-in-combination-with-or-without-famitinib-as-neoadjuvant-therapy-in-participant-31515https://curecurrent.com/trials/a-study-of-rc48-adc-administered-intravenously-to-patients-with-her2-positive-metastatic-breast-cancer-with-or-without-l-31516https://curecurrent.com/trials/pembrolizumab-and-enobosarm-in-treating-patients-with-androgen-receptor-positive-metastatic-triple-negative-breast-cance-31517https://curecurrent.com/trials/adding-adjuvant-cisplatin-and-gemicitabine-versus-capecitabine-in-triple-negative-breast-cancer-patients-in-non-pcr-afte-31518https://curecurrent.com/trials/thermobreast-non-contact-breast-cancer-imaging-using-ai-enhanced-thermography-31519https://curecurrent.com/trials/ipatasertib-in-combination-with-carboplatin-carboplatin-paclitaxel-or-capecitabine-atezolizumab-in-treating-patients-wit-31520https://curecurrent.com/trials/thoracic-paravertebral-block-anesthesia-for-breast-cancer-surgery-31521https://curecurrent.com/trials/patient-derived-organoid-guided-personalized-treatment-versus-treatment-of-physician-s-choice-in-breast-cancer-31522https://curecurrent.com/trials/proact-can-we-prevent-chemotherapy-related-heart-damage-in-patients-with-breast-cancer-and-lymphoma-31523https://curecurrent.com/trials/an-exercise-rct-targeting-african-american-women-with-metabolic-syndrome-and-high-risk-for-breast-cancer-31524https://curecurrent.com/trials/ribociclib-and-aromatase-inhibitor-in-treating-older-participants-with-hormone-receptor-positive-metastatic-breast-cance-31525https://curecurrent.com/trials/combined-pecs-ii-and-transversus-plane-blocks-versus-erector-spinae-block-in-modified-radical-mastectomy-31526https://curecurrent.com/trials/aerobic-dance-during-chemotherapy-in-breast-cancer-patients-with-cognitive-impairment-31527https://curecurrent.com/trials/the-effect-of-mobile-lymphedema-self-care-support-program-on-self-care-in-women-with-breast-cancer-related-lymphedema-31528https://curecurrent.com/trials/plasmodium-immunotherapy-for-breast-and-liver-cancers-31529https://curecurrent.com/trials/new-formula-to-predict-the-need-for-reconstructive-coverage-following-mastectomy-31530https://curecurrent.com/trials/hand-foot-exercises-on-peripheral-neuropathy-31531https://curecurrent.com/trials/oral-paclitaxel-efficacy-safety-and-pk-in-recurrent-and-metastatic-breast-cancer-31532https://curecurrent.com/trials/repeatability-of-68-ganota-anti-her2-vhh1-pet-ct-in-breast-carcinoma-patients-31533https://curecurrent.com/trials/breathing-exercise-for-chronic-pain-management-in-breast-cancer-survivors-31534https://curecurrent.com/trials/niraparib-plus-aromatase-inhibitors-for-luminal-like-her2-er-and-gbrca-or-hdr-metastatic-breast-cancer-luzern-31535https://curecurrent.com/trials/treatment-patterns-and-clinical-outcomes-among-talazoparib-treated-adults-with-her2-negative-mbc-with-gbrca1-2m-31536https://curecurrent.com/trials/the-effect-of-mindfulness-based-yoga-and-meditation-on-some-parameters-in-breast-cancer-patients-31537https://curecurrent.com/trials/effect-of-non-estrogenic-pollen-extract-pcc-100-on-hot-flushes-31538https://curecurrent.com/trials/transcriptional-and-epimetabolic-profile-of-breast-carcinoma-with-luminal-or-her2-or-locally-advanced-triple-negative-hi-31539https://curecurrent.com/trials/omission-of-axillary-surgery-in-breast-cancer-patients-31540https://curecurrent.com/trials/a-retrospective-breast-reconstruction-study-31541https://curecurrent.com/trials/virtual-reality-software-to-reduce-stress-in-cancer-patients-31542https://curecurrent.com/trials/family-history-study-on-cancer-risk-31543https://curecurrent.com/trials/electronic-medical-record-based-nudge-to-reduce-slnb-31544https://curecurrent.com/trials/comparison-of-conventional-with-sonography-assisted-breast-surgery-after-neoadjuvant-chemotherapy-31545https://curecurrent.com/trials/messaging-strategies-to-reduce-breast-cancer-over-screening-in-older-women-31546https://curecurrent.com/trials/impact-of-chemo-induced-menopause-on-quality-of-life-in-women-45-years-old-diagnosed-with-non-metastatic-breast-cancer-31547https://curecurrent.com/trials/lag3-expression-in-triple-negative-breast-cancer-31548https://curecurrent.com/trials/study-evaluating-the-utility-of-18f-fdg-pet-in-assessing-early-response-to-neoadjuvant-chemotherapy-in-patients-with-mam-31549https://curecurrent.com/trials/evaluation-of-the-unconformity-of-the-hormonal-status-of-metastatic-lesions-during-a-first-relapse-of-breast-cancer-init-31550https://curecurrent.com/trials/ala-induced-fluorescence-imaging-of-breast-cancers-using-the-handheld-prodigi-and-eagle-imaging-devices-31551https://curecurrent.com/trials/liposomal-doxorubicin-bevacizumab-and-everolimus-in-patients-with-locally-advanced-tnbc-with-tumors-predicted-insensitiv-31552https://curecurrent.com/trials/evaluate-the-clinical-benefit-of-a-post-operative-treatment-associating-radiotherapy-nivolumab-ipilimumab-versus-radioth-31553https://curecurrent.com/trials/a-study-of-al101-monotherapy-in-patients-with-notch-activated-triple-negative-breast-cancer-31554https://curecurrent.com/trials/study-of-dotatate-imaging-in-breast-cancer-31555https://curecurrent.com/trials/the-dosing-regimen-of-pyrotinib-in-her2-positive-advanced-first-line-breast-cancer-a-phase-ii-clinical-study-31556https://curecurrent.com/trials/sunitinib-in-treating-patients-with-newly-diagnosed-stage-ii-or-stage-iii-breast-cancer-that-can-be-removed-by-surgery-31557https://curecurrent.com/trials/adebrelimab-combined-with-fluzoparib-in-hrd-positive-hr-her2-advanced-breast-cancer-31558https://curecurrent.com/trials/adaptive-training-exercise-programs-for-improving-cardiorespiratory-fitness-after-breast-cancer-treatment-the-activate-t-31559https://curecurrent.com/trials/a-pilot-study-to-evaluate-the-effectiveness-of-pulsed-time-domain-optical-spectroscopy-for-monitoring-the-responses-in-n-31560https://curecurrent.com/trials/evaluating-the-ability-of-99mtc-tilmanocept-to-identify-clipped-nodes-in-breast-cancer-patients-undergoing-neoadjuvant-c-31561https://curecurrent.com/trials/a-study-of-pyrotinib-plus-capecitabine-combined-with-srt-in-her2-mbc-with-brain-metastases-31562https://curecurrent.com/trials/examining-bioactivity-of-pvsripo-in-invasive-breast-cancer-31563https://curecurrent.com/trials/study-of-crx100-as-monotherapy-and-in-combination-with-pembrolizumab-in-patients-with-advanced-solid-malignancies-31564https://curecurrent.com/trials/immune-therapy-in-hr-positive-her2-negative-metastatic-breast-cancer-enigma-bctop-l-m02-31565https://curecurrent.com/trials/retrospective-analysis-of-breast-biopsies-in-women-younger-than-40-years-old-31566https://curecurrent.com/trials/efficacy-and-safety-of-fluzoparib-combined-with-adjuvant-endocrine-therapy-for-hr-her2-snf3-subtype-early-breast-cancer-31567https://curecurrent.com/trials/the-suitability-of-sniff-dog-as-a-tool-in-screening-tumors-31568https://curecurrent.com/trials/bridge-proactive-psychiatry-consultation-and-case-management-for-patients-with-cancer-31569https://curecurrent.com/trials/efficacy-of-everolimus-combined-with-first-line-endocrine-therapy-for-hr-her2-snf1-subtype-advanced-breast-cancer-31570https://curecurrent.com/trials/development-of-a-cell-free-dna-assay-as-a-biomarker-for-predicting-early-non-response-to-therapy-in-metastatic-cancer-31571https://curecurrent.com/trials/evaluation-of-prognostic-factors-from-breast-cancer-to-bone-metastases-31572https://curecurrent.com/trials/artificial-intelligence-in-mammography-based-breast-cancer-screening-31573https://curecurrent.com/trials/study-in-letrozole-combined-with-metronomic-oral-cyclophosphamide-in-elderly-metastasis-breast-cancer-patients-31574https://curecurrent.com/trials/pilot-study-to-evaluate-the-effect-of-aromatase-inhibitor-therapy-on-pain-threshold-in-breast-cancer-patients-31575https://curecurrent.com/trials/quantifying-radiation-induced-skin-reactions-establishing-the-foundation-for-future-prediction-models-31576https://curecurrent.com/trials/trastuzumab-deruxtecan-t-dxd-with-pyrotinib-in-first-line-her2-positive-unresectable-or-metastatic-breast-cancer-trial-31577https://curecurrent.com/trials/physiological-biomarkers-of-cancer-treatment-related-fatigue-in-women-with-breast-cancer-31578https://curecurrent.com/trials/coronary-artery-calcium-and-cardiovascular-risk-factors-analysis-after-rt-or-breast-cancer-31579https://curecurrent.com/trials/parp-inhibitor-with-cdk4-6-inhibitor-and-endocrine-therapy-in-hr-her2-advanced-breast-cancer-31580https://curecurrent.com/trials/utrecht-cohort-for-multiple-breast-cancer-intervention-studies-and-long-term-evaluation-the-umbrella-cohort-31581https://curecurrent.com/trials/famitinib-in-combination-with-camrelizumab-and-tpc-in-the-first-line-treatment-of-immunomodulatory-locally-advanced-or-m-31582https://curecurrent.com/trials/vr-based-intervention-for-cognitive-restoration-31583https://curecurrent.com/trials/automated-quantification-of-coronary-artery-calcifications-on-radiotherapy-planning-cts-for-cardiovascular-risk-predicti-31584https://curecurrent.com/trials/purpose-in-life-survey-31585https://curecurrent.com/trials/effectiveness-of-a-cream-for-treatment-of-dermatitis-in-patients-whith-breast-cancer-31586https://curecurrent.com/trials/cli-and-far-for-intraoperative-margin-assessment-31587https://curecurrent.com/trials/the-effect-of-training-given-by-whatsapp-application-on-mamography-health-beliefs-and-behaviors-31588https://curecurrent.com/trials/neoadjuvant-treatment-pegylated-liposomal-doxorubicin-plus-cyclophosphamide-sequential-docetaxel-plus-trastuzumab-and-pe-31589https://curecurrent.com/trials/a-long-term-follow-up-study-for-cardiac-safety-in-the-patients-with-her2-breast-cancer-who-have-completed-the-sb3-g31-bc-31590https://curecurrent.com/trials/a-clinical-study-of-darcilil-combined-with-ai-combined-with-pyrrotinib-in-the-treatment-of-tpbc-31591https://curecurrent.com/trials/atezolizumab-plus-carboplatin-plus-nab-paclitaxel-31592https://curecurrent.com/trials/safety-and-pharmacokinetics-of-odm-209-31593https://curecurrent.com/trials/psyco-quality-of-life-and-procreation-brca1-2-31594https://curecurrent.com/trials/metformin-hydrochloride-in-treating-women-with-stage-i-or-stage-ii-breast-cancer-that-can-be-removed-by-surgery-31595https://curecurrent.com/trials/dose-determining-and-dose-confirmatory-study-to-investigate-the-optimal-dose-of-tamoxifen-in-breast-cancer-patients-acco-31596https://curecurrent.com/trials/a-dose-escalation-expansion-study-of-arx788-in-advanced-solid-tumors-subjects-with-her2-expression-ace-pan-tumor-01-31597https://curecurrent.com/trials/influence-of-intermittent-fasting-on-locally-advanced-breast-cancer-patients-31598https://curecurrent.com/trials/a-prospective-open-multicenter-single-arm-clinical-studie-of-docetaxel-carboplatin-combined-with-inetetamab-and-pyrotini-31599https://curecurrent.com/trials/neoadjuvant-dalpiciclib-plus-aromatase-inhibitors-in-luminal-b-her2-negative-breast-cancer-dancer-31600https://curecurrent.com/trials/tele-nursing-practices-based-on-technological-competence-theory-in-breast-cancer-patients-31601https://curecurrent.com/trials/pembrolizumab-and-ruxolitinib-phosphate-in-treating-patients-with-metastatic-stage-iv-triple-negative-breast-cancer-31602https://curecurrent.com/trials/cambridge-brain-mets-trial-1-31603https://curecurrent.com/trials/changes-in-phenotype-and-genotype-of-breast-cancers-during-the-metastatic-process-and-optimization-of-therapeutic-target-31604https://curecurrent.com/trials/21dif039-prone-to-supine-breast-mri-ii-p2s2-breast-mri-trial-31605https://curecurrent.com/trials/a-pre-operative-window-study-of-letrozole-plus-pr-agonist-megestrol-acetate-versus-letrozole-alone-in-post-menopausal-pa-31606https://curecurrent.com/trials/real-world-evaluation-of-lunit-insight-mmg-technology-31607https://curecurrent.com/trials/efficacy-and-safety-of-pd-l1-monoclonal-antibody-combined-with-metronomic-vex-in-advanced-triple-negative-breast-cancer-31608https://curecurrent.com/trials/magseed-and-magtrace-localization-for-breast-cancer-31609https://curecurrent.com/trials/efficacy-evaluation-of-enobosarm-monotherapy-in-treatment-of-ar-er-her2-metastatic-breast-cancer-31610https://curecurrent.com/trials/sentinel-lymph-node-localisation-with-an-ultra-low-dose-of-magtrace-in-breast-cancer-patients-31611https://curecurrent.com/trials/a-first-in-human-phase-i-open-label-multicenter-study-of-nm1f-anti-pvrig-in-patients-with-advanced-solid-tumors-31612https://curecurrent.com/trials/treatment-patterns-and-clinical-outcomes-among-patients-in-latin-america-receiving-first-line-palbociclib-combinations-f-31613https://curecurrent.com/trials/selective-avoidance-of-sentinel-lymph-node-biopsy-after-neoadjuvant-chemotherapy-in-her-2-positive-triple-negative-breas-31614https://curecurrent.com/trials/improving-cancer-screening-and-follow-up-in-community-health-centers-31615https://curecurrent.com/trials/premarking-of-axillary-nodes-before-start-of-neoadjuvant-chemotherapy-using-magnetic-approach-31616https://curecurrent.com/trials/physsurg-b-physical-activity-in-relation-to-surgical-operations-breast-cancer-31617https://curecurrent.com/trials/macssi-mastectomie-cellules-souches-surveillance-immunitaire-31618https://curecurrent.com/trials/ta-e-c-gp-versus-a-e-c-t-for-the-high-risk-tnbc-patients-and-validation-of-the-mrna-lncrna-signature-31619https://curecurrent.com/trials/satisfaction-efficacy-of-compression-using-surgical-gloves-in-chemo-induced-peripheral-neuropathies-31620https://curecurrent.com/trials/optimizing-treatment-focused-genetic-testing-in-cancer-31621https://curecurrent.com/trials/a-study-of-ac682-in-chinese-patients-with-er-her2-locally-advanced-or-metastatic-breast-cancer-31622https://curecurrent.com/trials/the-characteristics-treatment-patterns-and-prognosis-of-chinese-male-breast-cancer-a-real-world-study-31623https://curecurrent.com/trials/a-study-of-cart-tnmuc1-in-patients-with-tnmuc1-positive-advanced-cancers-31624https://curecurrent.com/trials/study-of-radiation-therapy-in-combination-with-darolutamide-degarelix-in-intermediate-risk-prostate-cancer-31625https://curecurrent.com/trials/erector-spinae-plane-block-versus-general-anesthesia-in-breast-cancer-surgeries-31626https://curecurrent.com/trials/conserving-surgery-in-inflammatory-breast-cancer-after-neoadjuvant-chemotherapy-31627https://curecurrent.com/trials/a-study-of-everolimus-plus-exemestane-in-chinese-postmenopausal-women-with-estrogen-receptor-positive-locally-advanced-r-31628https://curecurrent.com/trials/intra-operative-pet-ct-a-novel-approach-to-determine-excision-margins-in-lumpectomy-breast-cancer-31629https://curecurrent.com/trials/smmart-adaptive-clinical-treatment-act-trial-31630https://curecurrent.com/trials/axillary-lymph-node-tattoo-marking-study-31631https://curecurrent.com/trials/study-to-evaluate-the-safety-and-antitumor-activity-of-cx-2009-monotherapy-and-in-combination-with-cx-072-in-advanced-br-31632https://curecurrent.com/trials/prevention-of-paclitaxel-induced-peripheral-neuropathy-in-breast-cancer-patients-31633https://curecurrent.com/trials/soy-protein-and-breast-cancer-risk-reduction-31634https://curecurrent.com/trials/clinical-significance-of-supraclavicular-lymph-node-dissection-for-breast-cancer-31635https://curecurrent.com/trials/adipose-induced-regeneration-of-breast-skin-to-treat-post-mastectomy-radiation-injury-in-breast-cancer-patients-31636https://curecurrent.com/trials/chidamide-in-combination-with-abemaciclib-and-endocrinotherapy-doctor-s-choice-in-breast-cancer-patients-previously-trea-31637https://curecurrent.com/trials/a-phase-study-of-anlotinib-combined-with-tislelizumab-and-at-in-the-neoadjuvant-treatment-of-triple-negative-breast-canc-31638https://curecurrent.com/trials/blossom-smart-expander-technology-in-breast-reconstruction-in-participants-with-breast-cancer-undergoing-mastectomy-31639https://curecurrent.com/trials/lymphedema-severity-on-shoulder-joint-function-and-muscle-activation-patterns-in-breast-cancer-survivors-31640https://curecurrent.com/trials/real-world-outcomes-of-us-talazoparib-treated-patients-with-locally-advanced-or-metastatic-breast-cancer-31641https://curecurrent.com/trials/genetic-testing-for-breast-ovarian-pancreatic-and-prostate-cancers-31642https://curecurrent.com/trials/contrast-enhanced-mri-for-the-characterization-of-ductal-carcinoma-in-situ-dcis-31643https://curecurrent.com/trials/a-study-of-telegenetics-versus-usual-care-to-increase-access-to-cancer-genetic-services-31644https://curecurrent.com/trials/the-use-of-shengmai-san-to-prevent-anthracycline-sequential-trastuzumab-therapy-related-cardiac-toxicity-31645https://curecurrent.com/trials/assessment-of-periodontal-therapy-and-biofilm-management-in-breast-cancer-31646https://curecurrent.com/trials/study-to-assess-the-efficacy-and-safety-of-a-parp-inhibitor-for-the-treatment-of-brca-positive-advanced-breast-cancer-31647https://curecurrent.com/trials/effect-of-healing-touch-on-the-experience-of-women-undergoing-treatment-for-breast-cancer-31648https://curecurrent.com/trials/radioembolization-of-metastatic-breast-cancer-to-the-liver-as-a-2nd-3rd-line-therapy-31649https://curecurrent.com/trials/effectiveness-of-cohesive-bandage-on-axillary-web-syndrome-after-31650https://curecurrent.com/trials/impact-of-18f-fdg-pet-ct-versus-conventional-staging-in-the-management-of-patients-presenting-with-clinical-stage-iii-br-31651https://curecurrent.com/trials/shr-a1921-combined-with-bevacizumab-in-triple-negative-breast-cancer-with-brain-metastases-31652https://curecurrent.com/trials/evaluation-of-perforator-phase-contrast-angiography-in-developing-surgery-plans-for-patients-with-breast-cancer-undergoi-31653https://curecurrent.com/trials/alpha-radiation-emitters-device-for-the-treatment-of-newly-diagnosed-breast-carcinoma-patients-with-distant-metastases-31654https://curecurrent.com/trials/mind-programme-for-women-with-breast-cancer-nationwide-coverage-31655https://curecurrent.com/trials/laser-vs-hyaluronic-acid-for-gsm-in-breast-cancer-31656https://curecurrent.com/trials/clinical-study-of-high-intensity-focused-ultrasound-tumor-treatment-system-super-knife-in-the-treatment-of-breast-cancer-31657https://curecurrent.com/trials/study-of-mt-302-in-adults-with-advanced-or-metastatic-epithelial-tumors-31658https://curecurrent.com/trials/patterns-of-relapse-after-neoadjuvant-chemotherapy-in-breast-cancer-31659https://curecurrent.com/trials/the-effect-of-intraoperative-dexmedetomidine-on-postoperative-morphine-requirements-after-breast-cancer-surgery-31660https://curecurrent.com/trials/olaparib-maintenance-therapy-in-metastatic-breast-cancer-31661https://curecurrent.com/trials/effect-of-low-dose-metronomic-chemotherapy-in-metastatic-breast-cancer-31662https://curecurrent.com/trials/a-study-on-breast-cancer-patient-care-using-chatbot-and-video-education-for-radiation-therapy-brave-31663https://curecurrent.com/trials/a-study-to-evaluate-rucaparib-in-combination-with-other-anticancer-agents-in-participants-with-a-solid-tumor-seastar-31664https://curecurrent.com/trials/everolimus-with-investigator-s-choice-of-chemotherapy-in-advanced-triple-negative-breast-cancer-tnbc-with-luminal-androg-31665https://curecurrent.com/trials/study-of-cb-103-in-adult-patients-with-advanced-or-metastatic-solid-tumours-and-haematological-malignancies-31666https://curecurrent.com/trials/role-of-multi-modality-imaging-in-the-assessment-of-chemotherapy-related-cardiac-dysfunction-among-cancer-patients-31667https://curecurrent.com/trials/improving-the-breast-cancer-care-delivery-model-for-sex-and-gender-minority-survivors-intended-for-sgm-study-31668https://curecurrent.com/trials/necessity-of-post-mastectomy-radiotherapy-after-neoadjuvant-chemotherapy-and-mastectomy-31669https://curecurrent.com/trials/biodistribution-and-safety-of-the-pet-probes-18f-fprgd2-and-18f-fpprgd2-31670https://curecurrent.com/trials/the-p53-breast-cancer-trial-31671https://curecurrent.com/trials/study-to-compare-the-effects-of-repeated-doses-of-an-investigational-new-drug-and-a-placebo-on-appetite-in-advanced-canc-31672https://curecurrent.com/trials/factors-influencing-adherence-to-adjuvant-endocrine-therapy-31673https://curecurrent.com/trials/neoadjuvant-trastuzumab-pertuzumab-and-tucatinib-without-chemotherapy-in-her2-positive-breast-cancer-the-train-4-study-31674https://curecurrent.com/trials/treatment-patterns-and-clinical-outcomes-among-patients-with-hr-her2-mbc-receiving-palbociclib-combination-therapy-in-th-31675https://curecurrent.com/trials/axillary-node-dissection-versus-no-dissection-in-breast-cancer-with-positive-sentinel-lymph-node-31676https://curecurrent.com/trials/a-follow-up-study-of-women-evaluated-and-treated-for-infertility-31677https://curecurrent.com/trials/study-of-cadonilimab-ak104-plus-eribulin-vs-eribulin-monotherapy-for-recurrent-or-metastatic-triple-negative-breast-canc-31678https://curecurrent.com/trials/circulating-tumor-dna-to-monitor-response-to-neoadjuvant-chemotherapy-in-breast-cancer-31679https://curecurrent.com/trials/breast-lesion-in-ct-chest-31680https://curecurrent.com/trials/serum-estradiol-e2-levels-in-breast-cancer-patients-during-endocrine-therapy-by-high-performance-liquid-chromatography-t-31681https://curecurrent.com/trials/a-first-in-human-study-of-d-0502-alone-and-in-combination-with-palbociclib-in-women-with-advanced-or-metastatic-er-posit-31682https://curecurrent.com/trials/99mtc-abh2-spect-ct-in-breast-cancer-31683https://curecurrent.com/trials/evaluation-of-safety-and-efficacy-of-sodium-thiosulfate-byon5667-eye-drops-to-reduce-ocular-toxicity-in-cancer-patients-31684https://curecurrent.com/trials/patient-education-videos-to-improve-patients-experience-during-radiotherapy-treatment-a-national-project-31685https://curecurrent.com/trials/microwave-ablation-combined-with-camrelizumab-in-the-treatment-of-early-breast-cancer-31686https://curecurrent.com/trials/three-dimensional-ultrasound-and-spectroscopy-as-early-indicators-of-breast-cancer-response-to-neoadjuvant-treatment-31687https://curecurrent.com/trials/does-inclusion-of-diaphragmatic-breathing-exercises-in-complete-decongestive-therapy-provide-further-benefits-in-patient-31688https://curecurrent.com/trials/intelligent-remote-intervention-for-high-risk-breast-cancer-populations-31689https://curecurrent.com/trials/peri-operative-slow-paced-breathing-to-reduce-anxiety-in-breast-cancer-surgery-patients-31690https://curecurrent.com/trials/proclaim-cx-2009-a-trial-to-find-safe-and-active-doses-of-an-investigational-drug-cx-2009-for-patients-with-selected-sol-31691https://curecurrent.com/trials/hydromark-post-market-clinical-follow-up-study-31692https://curecurrent.com/trials/a-breast-cancer-treatment-decision-aid-for-women-aged-70-and-older-31693https://curecurrent.com/trials/follow-up-study-of-crocin-on-cardiac-function-protection-in-patients-with-breast-cancer-undergoing-neoadjuvant-chemother-31694https://curecurrent.com/trials/effect-of-topical-diclofenac-on-clinical-outcome-in-breast-cancer-patients-treated-with-capecitabine-31695https://curecurrent.com/trials/high-five-hifi-accelerated-partial-breast-irradiation-study-31696https://curecurrent.com/trials/stereotactic-radiotherapy-combined-with-adebrelimab-and-tcb-nab-paclitaxel-carboplatin-in-neoadjuvant-treatment-of-tnbc-31697https://curecurrent.com/trials/breast-cancer-study-of-stereotactic-body-radiation-therapy-sbrt-combined-neoadjuvant-treatment-31698https://curecurrent.com/trials/nir-fluorescent-molecular-probe-for-the-identification-of-breast-tissue-31699https://curecurrent.com/trials/development-of-a-questionnaire-to-evaluate-patient-expectations-for-breast-reconstruction-in-women-with-breast-cancer-or-31700https://curecurrent.com/trials/effect-of-aromatase-inhibitor-therapy-on-blood-vessel-function-in-postmenopausal-women-with-breast-cancer-31701https://curecurrent.com/trials/a-study-to-evaluate-patient-preference-and-satisfaction-of-subcutaneous-administration-of-the-fixed-dose-combination-of-31702https://curecurrent.com/trials/characterizing-breast-cancer-with-al18f-nota-fapi-04-pet-ct-pfb-02-31703https://curecurrent.com/trials/evaluation-of-different-imaging-modalities-in-regional-lymph-nodes-staging-in-patients-with-breast-cancer-31704https://curecurrent.com/trials/characterizing-breast-cancer-with-68ga-fapi-pet-ct-pfb-01-31705https://curecurrent.com/trials/a-phase-1b-trial-of-atrc-101-in-adults-with-advanced-solid-malignancies-31706https://curecurrent.com/trials/a-simplified-approach-to-predicting-the-malignancy-of-breast-lesions-nomogram-in-ultrasonography-31707https://curecurrent.com/trials/fredo-odx-study-french-data-on-outcomes-in-hr-her2-early-breast-cancer-patients-with-oncotypedx-recurrence-score-guided-31708https://curecurrent.com/trials/exercise-testing-for-early-stage-breast-cancer-patients-receiving-radiation-treatment-31709https://curecurrent.com/trials/quality-of-life-and-cosmetic-outcomes-of-breast-conserving-surgery-according-to-localization-method-31710https://curecurrent.com/trials/use-of-quantitative-ultrasound-to-guide-adaptive-chemotherapy-among-women-with-breast-cancer-31711https://curecurrent.com/trials/pain-neuroscience-education-and-graded-exposure-to-movement-in-breast-cancer-survivors-31712https://curecurrent.com/trials/liquid-biopsies-and-imaging-in-breast-cancer-31713https://curecurrent.com/trials/rogaratinib-palbociclib-y-fulvestrant-in-patients-with-breast-cancer-31714https://curecurrent.com/trials/a-study-of-sibp-01-or-cn-trastuzumab-plus-docetaxel-and-carboplatin-in-her2-positive-breast-cancer-31715https://curecurrent.com/trials/standard-or-comprehensive-radiation-therapy-in-treating-patients-with-early-stage-breast-cancer-previously-treated-with-31716https://curecurrent.com/trials/culturally-tailored-educational-and-support-program-to-increase-quality-of-life-among-korean-breast-cancer-survivors-31717https://curecurrent.com/trials/cvl237-tablets-in-the-treatment-of-advanced-solid-tumors-with-pten-deficiency-31718https://curecurrent.com/trials/ptc-guiding-neoadjuvant-treatment-in-breast-cancer-31719https://curecurrent.com/trials/three-dimensional-ultrasound-imaging-and-spectroscopy-for-characterizing-breast-masses-31720https://curecurrent.com/trials/immunotherapy-nhs-il12-bintrafusp-alfa-and-radiation-therapy-for-the-treatment-of-hormone-receptor-positive-her2-negativ-31721https://curecurrent.com/trials/identifying-biomarkers-for-chronic-pain-after-breast-cancer-treatment-31722https://curecurrent.com/trials/multifactorial-risk-assessment-for-breast-ovarian-cancer-risk-detection-31723https://curecurrent.com/trials/effect-of-bosu-exercises-added-to-complete-decongestive-treatment-on-balance-in-breast-cancer-associated-lymphedema-31724https://curecurrent.com/trials/endometrial-malignancy-in-breast-cancer-patients-with-or-without-aub-31725https://curecurrent.com/trials/outcome-of-15-versus-5-fractions-in-adjuvant-breast-radiotherapy-in-women-over-65-years-31726https://curecurrent.com/trials/an-umbrella-trial-based-on-molecular-pathway-for-patients-with-metastatic-tnbc-31727https://curecurrent.com/trials/hypo-fractionated-radiotherapy-in-breast-cancer-31728https://curecurrent.com/trials/detection-of-breast-cancer-with-non-invasive-method-based-on-dna-methylation-of-circulated-tumor-dna-pbmc-31729https://curecurrent.com/trials/a-pilot-trial-of-itraconazole-pharmacokinetics-in-patients-with-metastatic-breast-cancer-31730https://curecurrent.com/trials/the-effect-of-wearable-vibration-therapy-on-shoulder-functionality-in-individuals-receiving-adjuvant-radiotherapy-after-31731https://curecurrent.com/trials/study-comparing-the-pet-scan-and-mri-in-identifying-breast-malignancies-in-women-with-breast-abnormalities-31732https://curecurrent.com/trials/communication-in-breast-cancer-care-31733https://curecurrent.com/trials/a-phase-1-study-to-evaluate-paclitaxel-conjugated-cxc-receptor-4-antagonist-mb1707-in-patients-with-advanced-cancer-31734https://curecurrent.com/trials/milademetan-and-fulvestrant-in-gata3-mutant-er-her-advanced-or-metastatic-breast-cancer-31735https://curecurrent.com/trials/physical-training-and-cancer-a-multicenter-clinical-trial-31736https://curecurrent.com/trials/effect-of-tiva-propofol-vs-sevoflurane-anaesthetic-on-serum-biomarkers-and-on-pbmcs-in-breast-cancer-surgery-31737https://curecurrent.com/trials/a-study-of-mgd013-in-patients-with-unresectable-or-metastatic-neoplasms-31738https://curecurrent.com/trials/cpi-006-alone-and-in-combination-with-ciforadenant-and-with-pembrolizumab-for-patients-with-advanced-cancers-31739https://curecurrent.com/trials/clinical-outcomes-of-patients-undergoing-skin-reducing-mastectomies-31740https://curecurrent.com/trials/using-of-costimulatory-and-co-inhibatory-immune-checkpoints-as-diagnostic-and-prognostic-in-breast-cancer-31741https://curecurrent.com/trials/comparing-level-1-compression-sleeves-with-routine-care-in-preventing-breast-cancer-related-arm-lymphedema-31742https://curecurrent.com/trials/avoiding-low-value-treatments-in-older-women-with-early-stage-breast-cancer-piloting-a-patient-decision-aid-31743https://curecurrent.com/trials/a-phase-ii-clinical-study-of-treatment-with-disitamb-vedotin-plus-pyrotinib-in-her2-positive-early-breast-cancer-31744https://curecurrent.com/trials/cb-103-plus-nsai-in-luminal-advanced-breast-cancer-31745https://curecurrent.com/trials/use-of-virtual-reality-goggles-during-chemotherapy-infusion-to-reduce-anxiety-related-symptoms-31746https://curecurrent.com/trials/slnb-after-neoadjuvant-treatment-in-node-positive-patients-31747https://curecurrent.com/trials/a-study-of-225ac-fpi-1966-in-participants-with-advanced-solid-tumours-31748https://curecurrent.com/trials/trial-of-nivolumab-with-chemotherapy-as-neoadjuvant-treatment-in-inflammatory-breast-cancer-ibc-31749https://curecurrent.com/trials/a-study-to-describe-the-breast-cancer-patient-population-treatment-and-results-in-indian-patients-receiving-combinations-31750https://curecurrent.com/trials/tpiv100-and-sargramostim-for-the-treatment-of-her2-positive-stage-ii-iii-breast-cancer-in-patients-with-residual-disease-31751https://curecurrent.com/trials/evaluation-of-pregnancy-associated-plasma-protein-a-pappa-as-a-biomarker-in-breast-cancer-31752https://curecurrent.com/trials/manual-lymphatic-drainage-versus-standard-treatment-for-the-prevention-of-breast-cancer-related-lymphoedema-in-patients-31753https://curecurrent.com/trials/a-study-of-rc48-adc-in-subjects-with-advanced-breast-cancer-31754https://curecurrent.com/trials/evaluating-the-efficacy-of-neratinib-on-live-cell-her2-signaling-transduction-analysis-positive-triple-negative-breast-31755https://curecurrent.com/trials/l-nmma-plus-taxane-chemotherapy-in-refractory-locally-advanced-or-metastatic-triple-negative-breast-cancer-patients-31756https://curecurrent.com/trials/study-of-the-icg-distribution-in-the-margins-of-breast-cancer-after-tumorectomy-31757https://curecurrent.com/trials/silibinin-in-nsclc-and-bc-patients-with-single-brain-metastasis-silmet-31758https://curecurrent.com/trials/evaluation-of-the-impact-of-the-use-of-hypnotherapy-performed-by-a-virtual-reality-toolalong-the-care-pathway-of-patient-31759https://curecurrent.com/trials/investigation-of-ultrasound-imaging-and-spectroscopy-for-characterizing-breast-masses-31760https://curecurrent.com/trials/aerobic-and-strength-training-exercise-in-improving-fitness-and-arm-health-during-and-after-radiation-therapy-in-patient-31761https://curecurrent.com/trials/a-trial-of-a-new-magnetic-breast-marking-clip-31762https://curecurrent.com/trials/evaluate-the-use-of-the-magnetic-resonance-spectroscopy-in-determining-if-the-breast-tumor-is-benign-or-malignant-31763https://curecurrent.com/trials/ultrasound-imaging-and-spectroscopy-as-early-indicators-of-locally-advanced-breast-cancer-response-31764https://curecurrent.com/trials/optimized-rehabilitation-following-primary-breast-cancer-surgery-31765https://curecurrent.com/trials/the-canadian-us-integrative-oncology-study-31766https://curecurrent.com/trials/to-evaluate-a-phase-ia-ib-clinical-study-of-eg017-in-patients-with-advanced-breast-cancer-31767https://curecurrent.com/trials/a-multicenter-and-real-world-analysis-of-rc48-adc-in-patients-with-her2-positive-or-her2-low-expressing-locally-advanced-31768https://curecurrent.com/trials/noninvasive-assessment-of-lymphedema-among-breast-cancer-survivors-31769https://curecurrent.com/trials/photoacoustic-imaging-for-characterizing-breast-masses-and-breast-tumor-response-to-neoadjuvant-chemotherapy-31770https://curecurrent.com/trials/novel-mri-guided-ultrasound-stimulated-microbubble-radiation-treatment-for-patients-with-chest-wall-and-breast-cancer-31771https://curecurrent.com/trials/68-ga-rm2-pet-mri-in-imaging-patients-with-estrogen-receptor-positive-breast-cancer-31772https://curecurrent.com/trials/impact-of-a-predictive-model-on-sentinel-lymph-node-biopsy-in-initially-lymph-node-positive-her2-positive-breast-cancer-31773https://curecurrent.com/trials/a-dose-escalation-study-of-the-safety-and-pharmacology-of-dan-222-in-subjects-with-metastatic-breast-cancer-31774https://curecurrent.com/trials/digoxin-induced-dissolution-of-ctc-clusters-31775https://curecurrent.com/trials/comparative-analysis-of-two-animal-derived-adms-in-irradiated-implant-based-reconstruction-31776https://curecurrent.com/trials/a-study-to-assess-the-effect-of-azd5462-on-the-pharmacokinetics-of-midazolam-rosuvastatin-and-digoxin-31777https://curecurrent.com/trials/using-color-doppler-us-artifact-to-identify-tumor-markers-31778https://curecurrent.com/trials/phase-ii-trial-of-combination-immunotherapy-with-neuvax-and-trastuzumab-in-high-risk-her2-breast-cancer-patients-31779https://curecurrent.com/trials/ultrasound-imaging-spectroscopy-and-ultrasound-imaging-of-vascular-blood-flow-as-early-indicators-of-breast-cancer-respo-31780https://curecurrent.com/trials/a-study-of-palbociclib-in-addition-to-standard-endocrine-treatment-in-hormone-receptor-positive-her2-normal-patients-wit-31781https://curecurrent.com/trials/english-mammography-screening-outcomes-by-age-frequency-and-test-threshold-31782https://curecurrent.com/trials/phase-2-etirinotecan-pegol-in-refractory-brain-metastases-advanced-lung-cancer-metastatic-breast-cancer-31783https://curecurrent.com/trials/telehealth-program-to-prevent-cancer-and-chemotherapy-related-cognitive-impairment-31784https://curecurrent.com/trials/a-study-of-prt2527-in-participants-with-advanced-solid-tumors-31785https://curecurrent.com/trials/chemotherapy-bevacizumab-for-human-epidermal-growth-factor-receptor-2-her2-neu-negative-stage-ii-iii-breast-cancer-31786https://curecurrent.com/trials/tear-based-sample-collection-breast-cancer-detection-31787https://curecurrent.com/trials/intra-hepatic-chemotherapy-in-patients-with-liver-metastases-from-breast-cancer-and-limited-extrahepatic-disease-31788https://curecurrent.com/trials/a-tear-based-lab-developed-test-for-breast-cancer-for-women-with-dense-breast-tissue-31789https://curecurrent.com/trials/evaluate-rcn3028-in-treatment-of-drug-induced-vms-in-breast-cancer-31790https://curecurrent.com/trials/psychological-interventions-to-prevent-late-effects-in-breast-cancer-31791https://curecurrent.com/trials/evidence-based-dissemination-for-mammography-adherence-in-safety-net-communities-31792https://curecurrent.com/trials/phase-i-evaluating-the-combination-of-ribociclib-capecitabine-in-locally-advanced-metastatic-breast-cancer-her2-negative-31793https://curecurrent.com/trials/effect-of-ultrasound-combined-with-microbubbles-on-blood-perfusion-in-invasive-breast-cancer-31794https://curecurrent.com/trials/abbreviated-mri-protocol-initial-experience-with-dotarem-gadoterate-meglumine-31795https://curecurrent.com/trials/exercise-program-in-breast-cancer-patients-receiving-neoadjuvant-chemotherapy-31796https://curecurrent.com/trials/aging-mammary-stem-cells-and-breast-cancer-prevention-31797https://curecurrent.com/trials/light-emitting-diode-for-thetreatment-of-genitourinary-syndrome-of-menopause-associated-with-breast-cancer-treatment-31798https://curecurrent.com/trials/safety-of-gq1001-in-adult-patients-with-her2-positive-advanced-solid-tumors-31799https://curecurrent.com/trials/mitoxantrone-hydrochloride-liposome-combined-with-capecitabine-in-patients-with-her-2-negative-advanced-breast-cancer-31800https://curecurrent.com/trials/heading-off-peripheral-neuropathy-with-exercise-31801https://curecurrent.com/trials/nelipepimut-s-plus-gm-csf-vaccine-therapy-in-treating-patients-with-breast-cancer-31802https://curecurrent.com/trials/a-study-to-evaluate-talazoparib-radiotherapy-and-atezolizumab-in-gbrca-1-2-negative-patients-with-pd-l1-metastatic-tripl-31803https://curecurrent.com/trials/density-lowering-effect-of-ofs-add-on-to-tmx-delfino-trial-31804https://curecurrent.com/trials/a-study-of-monosialic-gangliosides-to-prevent-albumin-bound-paclitaxel-neurotoxicity-31805https://curecurrent.com/trials/study-of-bkm120-or-byl719-and-capecitabine-in-patients-with-metastatic-breast-cancer-31806https://curecurrent.com/trials/anastrozole-adjuvant-trial-study-of-anastrozole-compared-to-nolvadex-tamoxifen-citrate-for-adjuvant-treatment-of-early-b-31807https://curecurrent.com/trials/16-18f-fluor-17-estradiol-pet-ct-for-visualisation-of-estrogen-receptor-positive-liver-metastases-from-breast-cancer-31808https://curecurrent.com/trials/pyrotinib-combined-with-capecitabine-and-bevacizumab-for-patients-with-her2-positive-breast-cancer-and-brain-metastases-31809https://curecurrent.com/trials/an-eortc-study-updating-the-qlq-br23-to-br45-31810https://curecurrent.com/trials/comparative-efficacy-of-xiaopi-granules-and-decoction-in-triple-negative-breast-cancer-a-randomized-controlled-trial-31811https://curecurrent.com/trials/vitamin-d-and-calcium-supplementation-in-breast-cancer-31812https://curecurrent.com/trials/salud-en-mis-manos-breast-and-cervical-cancer-prevention-and-early-detection-expansion-1-31813https://curecurrent.com/trials/prevention-of-osteoporosis-in-breast-cancer-survivors-31814https://curecurrent.com/trials/trilaciclib-in-patients-with-early-stage-hr-negative-breast-cancer-receiving-adjuvant-chemotherapy-31815https://curecurrent.com/trials/study-of-efficacy-and-safety-of-lee011-in-men-and-postmenopausal-women-with-advanced-breast-cancer-31816https://curecurrent.com/trials/paclitaxel-plus-radiation-therapy-in-treating-women-with-stage-ii-or-stage-iii-breast-cancer-31817https://curecurrent.com/trials/early-rehabilitation-for-breast-cancer-a-randomized-control-trial-31818https://curecurrent.com/trials/evaluate-the-meritup-oral-solution-to-decrease-fatigue-in-metastatic-breast-cancer-patients-receiving-chemotherapy-31819https://curecurrent.com/trials/regional-anesthesia-for-modified-radical-mastectomy-with-axillary-lymph-node-dissection-31820https://curecurrent.com/trials/effect-of-salovum-and-spc-flakes-on-abemaciclib-induced-gastrointestinal-toxicity-in-early-breast-cancer-31821https://curecurrent.com/trials/weight-reduction-intervention-for-breast-cancer-survivors-31822https://curecurrent.com/trials/muscle-parameters-and-pathological-response-in-breast-cancer-patients-31823https://curecurrent.com/trials/a-dose-escalation-and-expansion-study-of-trx518-in-combination-with-cyclophosphamide-plus-avelumab-in-advanced-solid-tum-31824https://curecurrent.com/trials/overcome-a-program-of-therapeutic-exercise-and-functional-recovery-to-improve-the-functional-capacity-of-women-with-brea-31825https://curecurrent.com/trials/effect-of-early-removal-of-wound-drains-after-mastectomy-or-lymph-node-dissection-31826https://curecurrent.com/trials/effect-of-adding-ttpb-to-sapb-in-breast-cancer-surgery-31827https://curecurrent.com/trials/micrometastases-in-axillary-lymph-nodes-in-breast-cancer-post-neoadjuvant-chemotherapy-31828https://curecurrent.com/trials/mass-balance-study-of-tqb3616-31829https://curecurrent.com/trials/opti-dose-optimal-dosing-of-oral-anticancer-drugs-in-older-adults-31830https://curecurrent.com/trials/effects-of-moderate-and-high-intensity-exercise-during-chemotherapy-on-muscle-cells-in-women-with-breast-cancer-31831https://curecurrent.com/trials/evaluation-of-innovative-therapeutic-approaches-of-vaginal-and-sexual-dysfunction-after-breast-cancer-treatment-31832https://curecurrent.com/trials/a-combined-exercise-training-program-for-women-living-with-breast-cancer-31833https://curecurrent.com/trials/text-messaging-in-patients-on-adjuvant-endocrine-therapy-for-breast-cancer-31834https://curecurrent.com/trials/association-of-adjuvant-radiotherapy-of-non-metastatic-breast-carcinoma-with-immunomodulation-and-circulating-tumor-cell-31835https://curecurrent.com/trials/self-administered-acupressure-to-improve-cancer-related-fatigue-among-cancer-patients-undergoing-chemotherapy-31836https://curecurrent.com/trials/breast-mri-in-women-with-known-or-suspected-breast-cancer-and-in-healthy-participants-31837https://curecurrent.com/trials/fulvestrant-with-or-without-bortezomib-in-patients-with-inoperable-locally-advanced-or-metastatic-estrogen-receptor-posi-31838https://curecurrent.com/trials/capecitabine-and-radiotherapy-in-the-adjuvant-treatment-of-resistant-breast-cancer-31839https://curecurrent.com/trials/randomized-study-of-elective-regional-lymph-node-irradiation-in-n1-breast-cancer-31840https://curecurrent.com/trials/a-study-of-atherosclerosis-in-patients-after-radiation-treatment-for-breast-cancer-31841https://curecurrent.com/trials/evaluation-of-taihao-breast-ultrasound-diagnosis-software-rn-ces-descartes-31842https://curecurrent.com/trials/a-study-of-abemaciclib-in-indian-women-with-advanced-breast-cancer-31843https://curecurrent.com/trials/clip-marker-placement-in-primary-lesions-of-breast-cancer-patients-receiving-neoadjuvant-therapy-31844https://curecurrent.com/trials/investigating-the-biological-effects-of-the-addition-of-zoledronic-acid-to-pre-operative-chemotherapy-in-breast-cancer-31845https://curecurrent.com/trials/study-of-radium-223-dichloride-in-combination-with-exemestane-and-everolimus-versus-placebo-in-combination-with-exemesta-31846https://curecurrent.com/trials/adapted-physical-activity-for-breast-cancer-her2-positive-patient-31847https://curecurrent.com/trials/treatment-of-advanced-or-metastatic-triple-negative-breast-cancer-with-adoptive-therapy-of-pd1-tils-31848https://curecurrent.com/trials/galunisertib-and-paclitaxel-in-treating-patients-with-metastatic-androgen-receptor-negative-ar-triple-negative-breast-ca-31849https://curecurrent.com/trials/pelareorep-and-paclitaxel-injection-in-chinese-patients-with-advanced-or-metastatic-breast-cancer-31850https://curecurrent.com/trials/epcam-car-t-for-treatment-of-advanced-solid-tumors-31851https://curecurrent.com/trials/metastases-directed-therapy-for-oligometastatic-breast-cancer-31852https://curecurrent.com/trials/fasting-mimicking-diet-program-to-improve-chemotherapy-in-hormone-receptor-postive-hr-her2-breast-cancer-31853https://curecurrent.com/trials/a-window-of-opportunity-study-of-pre-operative-endocrine-therapy-with-and-without-prometrium-in-postmenopausal-women-wit-31854https://curecurrent.com/trials/healthy-me-advancing-health-equity-in-lymphatic-pain-and-lymphedema-in-black-and-hispanic-women-with-breast-cancer-31855https://curecurrent.com/trials/transversus-thoracic-muscle-plane-combined-with-pectoral-nerves-block-for-breast-cancer-surgery-31856https://curecurrent.com/trials/correlate-brca1-protein-expression-with-response-to-dna-damaging-chemotherapy-31857https://curecurrent.com/trials/radioembolisation-and-chemotherapy-in-liver-metastatic-breast-cancer-patients-31858https://curecurrent.com/trials/comparison-of-mri-and-cedm-to-evaluate-treatment-response-before-surgery-31859https://curecurrent.com/trials/a-study-of-shr6390-in-combination-with-letrozole-or-anastrozole-or-fulvestrant-in-patients-with-hr-positive-and-her2-neg-31860https://curecurrent.com/trials/the-efficacy-and-safety-of-lenvatinib-combined-with-sindilimab-and-nab-paclitaxel-in-the-first-line-treatment-for-recurr-31861https://curecurrent.com/trials/concordance-of-the-ihc4-score-performed-in-local-or-central-laboratory-to-endopredict-in-er-her2-breast-cancer-31862https://curecurrent.com/trials/aldh1a1-expression-in-invasive-mammary-carcinoma-31863https://curecurrent.com/trials/fdg-pet-and-dce-mri-in-predicting-response-to-treatment-in-patients-with-breast-cancer-31864https://curecurrent.com/trials/ispy-p1-01-evaluating-the-safety-of-weekly-paclitaxel-with-trastuzumab-duocarmazine-syd985-in-patients-with-metastatic-c-31865https://curecurrent.com/trials/three-birds-with-one-stone-31866https://curecurrent.com/trials/mulm-to-support-breast-cancer-diagnosis-and-therapy-31867https://curecurrent.com/trials/efficacy-of-t-dxd-in-the-treatment-of-her2-positive-bcbm-after-prior-pyrotinib-31868https://curecurrent.com/trials/soy-isoflavones-supplementation-in-treating-women-at-high-risk-for-or-with-breast-cancer-31869https://curecurrent.com/trials/post-market-clinical-follow-up-to-patient-reported-outcome-using-a-titanised-polypropylene-mesh-tiloop-bra-pocket-31870https://curecurrent.com/trials/dalpiciclib-combination-with-fulvestrant-and-compound-gossyfol-acetate-tablets-in-women-with-cdk4-6-inhibitor-refractory-31871https://curecurrent.com/trials/study-of-tremelimumab-in-patients-with-advanced-solid-tumors-31872https://curecurrent.com/trials/patient-reported-outcomes-using-mepitel-film-during-radiotherapy-31873https://curecurrent.com/trials/move-together-boston-feasibility-pilot-sit-less-move-more-app-for-black-breast-cancer-survivors-at-risk-relatives-31874https://curecurrent.com/trials/feasibility-of-providing-a-purpose-renewal-intervention-for-cancer-survivors-via-virtual-groups-31875https://curecurrent.com/trials/sentinel-lymph-node-biopsy-after-neoadjuvant-chemotherapy-in-initially-node-positive-breast-cancer-patients-could-it-omi-31876https://curecurrent.com/trials/study-comparing-4-cycles-with-6-cycles-of-tc-docetaxel-cyclophosphamide-adjuvant-chemotherapy-for-1-3-lymph-node-positiv-31877https://curecurrent.com/trials/spatial-location-of-breast-cancer-local-recurrence-after-mastectomy-31878https://curecurrent.com/trials/trial-of-a-mammography-decision-aid-for-women-aged-75-and-older-31879https://curecurrent.com/trials/surgical-or-medical-treatment-of-breast-cancer-metastasis-a-multicentre-observational-study-31880https://curecurrent.com/trials/breast-cancer-risk-assessment-in-women-aged-40-49-31881https://curecurrent.com/trials/body-awareness-and-functionality-in-lymphedema-31882https://curecurrent.com/trials/evaluation-of-medical-treatments-in-mbc-patients-according-biological-subtype-and-line-of-treatments-31883https://curecurrent.com/trials/the-perspective-of-healthy-individuals-on-breast-cancer-risk-prediction-report-in-the-indonesian-population-31884https://curecurrent.com/trials/emotion-regulation-and-cancer-caregiving-31885https://curecurrent.com/trials/clinical-study-of-cea-targeting-chimeric-antigen-receptor-t-lymphocytes-car-t-for-cea-positive-advanced-malignant-solid-31886https://curecurrent.com/trials/improving-well-being-for-breast-cancer-patients-31887https://curecurrent.com/trials/tucatinib-palbociclib-and-letrozole-in-metastatic-hormone-receptor-positive-and-her2-positive-breast-cancer-31888https://curecurrent.com/trials/overcoming-therapy-resistance-in-er-breast-cancer-patients-a-translational-project-overture-31889https://curecurrent.com/trials/memory-and-attention-adaptation-training-geriatrics-maat-g-31890https://curecurrent.com/trials/effects-of-pinkwashed-alcohol-ads-in-an-online-rct-31891https://curecurrent.com/trials/evaluation-protocols-for-isolation-of-analytes-from-urine-for-future-oncology-applications-31892https://curecurrent.com/trials/feasibility-and-therapeutic-efficacy-of-ductoscopic-papilloma-extraction-in-patients-with-pathologic-nipple-discharge-31893https://curecurrent.com/trials/the-effect-of-melatonin-supplementation-on-fatigue-symptoms-during-chemotherapy-treatment-of-breast-cancer-patients-31894https://curecurrent.com/trials/the-efficacy-and-safety-of-utidelone-plus-tirelizumab-and-bevacizumab-for-advanced-or-metastatic-triple-negative-breast-31895https://curecurrent.com/trials/shear-wave-elastography-in-breast-cancer-31896https://curecurrent.com/trials/movement-and-health-beyond-care-movis-31897https://curecurrent.com/trials/a-trial-of-ribocilcib-lee011-and-weekly-paclitaxel-in-patients-with-rb-advanced-breast-cancer-31898https://curecurrent.com/trials/phase-i-ii-trial-of-letrozole-and-sorafenib-in-post-menopausal-hormone-receptor-breast-cancer-31899https://curecurrent.com/trials/the-effect-of-walking-exercise-based-on-tous-on-peripheral-neuropathy-and-arthralgia-myalgia-in-women-with-breast-cancer-31900https://curecurrent.com/trials/pilot-study-of-oxytocin-and-microrna-identification-in-naf-serum-and-tissue-in-women-with-breast-cancer-31901https://curecurrent.com/trials/body-composition-and-white-adipose-tissue-inflammation-31902https://curecurrent.com/trials/a-research-study-for-latina-women-with-breast-cancer-31903https://curecurrent.com/trials/phase-i-study-of-autologous-tumor-draining-lymph-node-derived-lymphocytes-for-advanced-her2-negative-breast-cancer-31904https://curecurrent.com/trials/accelerated-partial-irradiation-of-the-breast-new-altered-fractionation-31905https://curecurrent.com/trials/evaluation-of-mepitel-film-in-preventing-epidermitis-in-patients-receiving-radiation-therapy-for-breast-cancer-31906https://curecurrent.com/trials/clinical-validation-of-an-artificial-intelligence-algorithm-to-help-interpret-mammograms-31907https://curecurrent.com/trials/utidelone-in-combination-with-ac-versus-docetaxel-in-combination-with-ac-for-neoadjuvant-chemotherapy-in-patients-with-h-31908https://curecurrent.com/trials/breast-cancer-and-cardiotoxicity-induced-by-radiotherapy-the-baccarat-study-31909https://curecurrent.com/trials/atrial-fibrillation-and-other-cardiac-arrhythmias-and-diseases-after-radiotherapy-for-breast-cancer-watch-your-heart-31910https://curecurrent.com/trials/clinical-study-of-cea-targeted-car-t-therapy-for-cea-positive-advanced-metastatic-malignant-solid-tumors-31911https://curecurrent.com/trials/study-of-pf-07224826-as-a-single-agent-or-in-combination-with-endocrine-therapy-in-participants-with-breast-cancer-and-o-31912https://curecurrent.com/trials/phase-i-study-of-autologous-tumor-draining-lymph-node-derived-lymphocytes-as-neoadjuvant-therapy-for-her2-negative-breas-31913https://curecurrent.com/trials/a-study-to-develop-molecular-integrated-predictive-models-of-breast-radio-toxicity-precise-rtox-31914https://curecurrent.com/trials/photoacoustic-lymph-node-imaging-31915https://curecurrent.com/trials/tap-vs-ql-for-postoperative-analgesia-after-diep-free-flap-breast-reconstruction-31916https://curecurrent.com/trials/neoadjuvant-tchp-versus-thp-in-patients-with-her2-positive-breast-cancer-neocarhp-study-31917https://curecurrent.com/trials/early-detection-of-cardiovascular-changes-after-radiotherapy-for-breast-cancer-31918https://curecurrent.com/trials/treating-verbal-memory-deficits-following-chemotherapy-for-breast-cancer-31919https://curecurrent.com/trials/targeted-axillary-dissection-after-neo-adjuvant-chemotherapy-31920https://curecurrent.com/trials/pipac-nab-pac-for-stomach-pancreas-breast-and-ovarian-cancer-31921https://curecurrent.com/trials/risk-prediction-of-taxane-chemotherapy-induced-peripheral-neuropathy-31922https://curecurrent.com/trials/lymphatic-response-to-resistance-exercise-in-breast-cancer-survivors-31923https://curecurrent.com/trials/restore-b-a-trial-comparing-prepectoral-implant-based-breast-reconstruction-with-and-without-mesh-31924https://curecurrent.com/trials/vaccine-response-with-nt-i7-31925https://curecurrent.com/trials/tamoxifen-prediction-study-in-patients-with-er-breast-cancer-31926https://curecurrent.com/trials/single-pre-operative-radiation-therapy-sport-for-low-risk-breast-cancer-31927https://curecurrent.com/trials/effect-of-omega-3-fatty-acids-on-lactation-period-31928https://curecurrent.com/trials/pivotal-study-in-her2-negative-locally-recurrent-or-metastatic-breast-cancer-31929https://curecurrent.com/trials/clinical-evaluation-of-a-computer-algorithm-to-report-breast-cancers-cleopatraa-31930https://curecurrent.com/trials/shared-decision-making-with-breast-cancer-patients-31931https://curecurrent.com/trials/factors-affecting-weight-gain-in-women-receiving-adjuvant-chemotherapy-for-breast-cancer-31932https://curecurrent.com/trials/pet-mri-for-axillary-staging-in-node-negative-breast-cancer-patients-31933https://curecurrent.com/trials/aryotrust-trastuzumab-safety-study-31934https://curecurrent.com/trials/the-impact-of-adverse-events-produced-by-antibodies-conjugates-on-quality-of-life-in-patients-with-metastatic-breast-can-31935https://curecurrent.com/trials/assessment-of-the-mutation-of-pig-a-gene-as-biomarker-of-genotoxic-exposure-in-humans-31936https://curecurrent.com/trials/a-study-evaluating-the-safety-pharmacokinetics-and-efficacy-of-ipatasertib-administered-in-combination-with-rucaparib-in-31937https://curecurrent.com/trials/til-therapy-for-patients-with-advanced-solid-tumors-31938https://curecurrent.com/trials/phase-iii-clinical-trial-comparing-the-safety-efficacy-and-immunogenicity-of-hs022-and-trastuzumab-in-combination-with-v-31939https://curecurrent.com/trials/99mtc-my6349-spect-ct-imaging-in-trop2-positive-triple-negative-breast-cancer-31940https://curecurrent.com/trials/use-of-gnrha-during-chemotherapy-for-fertility-protection-31941https://curecurrent.com/trials/a-study-of-sy-5609-a-selective-cdk7-inhibitor-in-advanced-solid-tumors-31942https://curecurrent.com/trials/limbo-breast-reconstruction-by-lipomodeling-alone-or-with-flap-evaluation-in-franche-comt-31943https://curecurrent.com/trials/single-dose-partial-breast-radiotherapy-31944https://curecurrent.com/trials/prospective-ultrafast-mri-radiomics-for-breast-cancer-31945https://curecurrent.com/trials/pain-after-breast-surgery-31946https://curecurrent.com/trials/diagnostic-biomarkers-exploration-of-breast-cancer-from-serum-and-urine-31947https://curecurrent.com/trials/a-study-to-investigate-atezolizumab-and-chemotherapy-compared-with-placebo-and-chemotherapy-in-the-neoadjuvant-setting-i-31948https://curecurrent.com/trials/survival-of-bcs-vs-mx-in-asymptomatic-screen-detected-npbc-31949https://curecurrent.com/trials/post-mastectomy-shoulder-pain-and-lymphedema-responses-to-ga-as-laser-versus-microcurrent-electrical-stimulation-31950https://curecurrent.com/trials/single-dose-escalation-study-of-bivatuzumab-mertansine-in-female-patients-with-cd44v6-positive-metastatic-breast-cancer-31951https://curecurrent.com/trials/study-to-assess-the-safety-and-efficacy-of-ribociclib-lee011-in-combination-with-letrozole-for-the-treatment-of-men-and-31952https://curecurrent.com/trials/serum-retinoic-acid-induced-protein-14-rai14-and-metastasis-associated-cancer-colon-1-macc-1-in-breast-cancer-31953https://curecurrent.com/trials/dose-escalation-of-bivatuzumab-mertansine-in-female-patients-with-cd44v6-positive-recurrent-or-metastatic-breast-cancer-31954https://curecurrent.com/trials/comparing-the-pharmacokinetic-profile-of-ly01612-and-caelyx-in-chinese-subjects-with-advanced-breast-cancer-31955https://curecurrent.com/trials/emdr-psychotherapy-for-anxious-depressive-symptoms-in-breast-cancer-patient-31956https://curecurrent.com/trials/prospective-radiomics-study-for-breast-cancer-31957https://curecurrent.com/trials/nerve-coaptation-in-ltp-flap-breast-reconstruction-31958https://curecurrent.com/trials/multicenter-prospective-cohort-of-informal-caregivers-in-burgundy-and-franche-comt-31959https://curecurrent.com/trials/improving-lifestyle-behavior-by-joven-fuerte-y-saludable-multidisciplinary-program-31960https://curecurrent.com/trials/effect-of-rocuronium-on-bis-values-31961https://curecurrent.com/trials/amt-151-in-patients-with-selected-advanced-solid-tumours-31962https://curecurrent.com/trials/evaluating-the-impact-of-evidence-based-information-about-mammography-on-breast-cancer-screening-decisions-31963https://curecurrent.com/trials/syd985-vs-physician-s-choice-in-participants-with-her2-positive-locally-advanced-or-metastatic-breast-cancer-31964https://curecurrent.com/trials/neoadjuvant-zoledronate-and-atorvastatin-in-triple-negative-breast-cancer-31965https://curecurrent.com/trials/registry-of-local-recurrences-after-breast-conserving-surgery-31966https://curecurrent.com/trials/a-registry-of-intra-operative-radiation-therapy-iort-using-the-xoft-axxent-ebx-system-patients-31967https://curecurrent.com/trials/the-effectiveness-of-psychological-interventions-in-psycho-neuroendocrine-immune-network-in-breast-cancer-survivors-31968https://curecurrent.com/trials/the-role-of-emotional-processing-in-improving-the-quality-of-life-of-breast-cancer-patients-31969https://curecurrent.com/trials/a-phase-ii-study-of-t-dxd-plus-srt-in-her2-positive-breast-cancer-brain-metastases-31970https://curecurrent.com/trials/safety-of-omitting-axillary-surgery-in-breast-cancer-patients-with-isolated-chest-wall-recurrence-31971https://curecurrent.com/trials/partial-chest-wall-radiation-therapy-after-surgery-for-lymph-node-negative-breast-cancer-31972https://curecurrent.com/trials/a-study-of-codalytic-an-intratumoral-oncolytic-virus-in-patients-with-breast-cancer-31973https://curecurrent.com/trials/komen-breast-cancer-survivor-health-screening-promotion-project-staying-healthy-31974https://curecurrent.com/trials/a-phase-1-multi-center-open-label-dose-escalation-safety-pharmacokinetic-and-pharmacodynamic-study-of-minnelide-capsules-31975https://curecurrent.com/trials/immunomonitoring-of-breast-cancer-patients-during-systemic-treatment-31976https://curecurrent.com/trials/neoadjuvant-tucidinostat-and-exemestane-in-early-breast-cancer-31977https://curecurrent.com/trials/optimizing-the-management-of-patients-with-oral-therapy-31978https://curecurrent.com/trials/relevance-of-t-lymphocytes-tumor-infiltrates-cd8-and-foxp3-as-immune-prognostic-biomarker-in-breast-cancer-treated-by-ne-31979https://curecurrent.com/trials/stereotactic-radiosurgery-vs-whole-brain-radiotherapy-in-breast-cancer-with-brain-oligometastasis-31980https://curecurrent.com/trials/whole-brain-radiation-therapy-or-stereotactic-radiosurgery-with-or-without-lapatinib-ditosylate-in-treating-patients-wit-31981https://curecurrent.com/trials/osteopathy-and-prevention-of-gastrointestinal-side-effects-in-women-treated-for-breast-cancer-31982https://curecurrent.com/trials/a-therapy-treatment-response-trial-in-patients-with-leptomeningeal-metastases-lm-using-cnside-31983https://curecurrent.com/trials/subzero-and-scorpion-trial-31984https://curecurrent.com/trials/trigger-point-injections-for-post-mastectomy-pain-syndrome-31985https://curecurrent.com/trials/a-prospective-multi-site-clinical-study-to-collect-user-feedback-using-affirm-contrast-biopsy-31986https://curecurrent.com/trials/achp-thp-vs-ec-thp-as-neoadjuvant-therapy-for-her2-positive-ebc-31987https://curecurrent.com/trials/medroxyprogesterone-cyclophosphamide-methotrexate-in-hormone-receptor-negative-recurrent-metastatic-breast-cancer-31988https://curecurrent.com/trials/a-pilot-pre-operative-window-trial-of-black-cohosh-in-women-with-ductal-carcinoma-in-situ-31989https://curecurrent.com/trials/breast-cancer-and-resistance-exercise-program-31990https://curecurrent.com/trials/javelin-parp-medley-avelumab-plus-talazoparib-in-locally-advanced-or-metastatic-solid-tumors-31991https://curecurrent.com/trials/the-choice-of-treatment-methods-and-efficacy-of-labc-31992https://curecurrent.com/trials/risk-based-breast-screening-in-young-women-31993https://curecurrent.com/trials/can-exercise-training-reduce-the-frequency-and-severity-of-hot-flushes-associated-with-breast-cancer-treatment-31994https://curecurrent.com/trials/parp-inhibitor-cvl218-in-combination-therapy-for-patients-with-advanced-solid-tumors-31995https://curecurrent.com/trials/using-a-lay-health-worker-program-to-increase-breast-and-cervical-cancer-screening-in-low-income-hispanic-women-31996https://curecurrent.com/trials/performance-of-contrast-enhanced-spectral-mammography-to-assess-neoadjuvant-chemotherapy-response-cedm-31997https://curecurrent.com/trials/repeat-sentinel-lymph-node-biopsy-in-ipsilateral-breast-tumor-recurrence-31998https://curecurrent.com/trials/primary-surgical-prevention-of-breast-cancer-related-lymphedema-31999https://curecurrent.com/trials/t-dm1-alone-versus-t-dm1-and-metronomic-temozolomide-in-secondary-prevention-of-her2-positive-breast-cancer-brain-metast-32000